Section 49

EurekaMag Full Text Articles Chapter 48,835


Vásquez-Campos, L.; Asencios-Solis, L.; Leo-Hurtado, E.; Quispe-Torres, N.; Salazar-Lindo, E.; Bayona, J.; Becerra, M.C. 2004: Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001. international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease 8(4): 465-472
Good, M.G. 1956: Drug resistance, a general principle in pharmacology and its application in dermatology and medicine. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 11(24): 1120-1125
Chen, R.; Quinones-Mateu, M.E.; Mansky, L.M. 2004: Drug resistance, virus fitness and HIV-1 mutagenesis. Current Pharmaceutical Design 10(32): 4065-4070
Bennett, T.N.; Kosar, A.D.; Ursos, L.M.B.; Dzekunov, S.; Singh Sidhu, A.B.; Fidock, D.A.; Roepe, P.D. 2004: Drug resistance-associated pfCRT mutations confer decreased Plasmodium falciparum digestive vacuolar pH. Molecular and Biochemical Parasitology 133(1): 99-114
Treffers, H.P. 1954: Drug resistance; today's research and to-morrow's medicine. New Zealand Medical Journal 53(298): 561-568
Murakami, K.; Fujioka, T. 2005: Drug resistant H. pylori in Japan: general remarks. Nihon Rinsho. Japanese Journal of Clinical Medicine 63 Suppl. 11: 198-202
Anonymous 2005: Drug resistant HIV lingers in female genital tract. Transmission of resistance feared. Aids Alert 20(5): 53-54
Majczyna, D.; Białasiewicz, D. 2004: Drug resistant coagulase-positive staphylococci strains in food. Medycyna Doswiadczalna i Mikrobiologia 56(1): 11-17
Taylor, W.R.; Rigal, J.; Olliaro, P.L. 2003: Drug resistant falciparum malaria and the use of artesunate-based combinations: focus on clinical trials sponsored by TDR. Journal of Vector Borne Diseases 40(3-4): 65-72
Feizabadi, M.Mehdi.; Asadi, S.; Aliahmadi, A.; Parvin, M.; Parastan, R.; Shayegh, M.; Etemadi, G. 2004: Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003. International journal of antimicrobial agents 24(5): 521-522
Knight, V.; White, A.C. 1956: Drug resistant staphylococci. I. their distribution in hospital patients. Southern Medical Journal 49(10): 1173-1187
Knight, V.; White, A.C. 1956: Drug resistant staphylococci. II. their role in human infection. Southern Medical Journal 49(11): 1356-1362
Popov, A.F.; Popova, N.I.; Chirkov, V.P.; Kamara, F. 2003: Drug resistant tropical malaria in the Republic of Guinea (West Africa). Meditsinskaia Parazitologiia i Parazitarnye Bolezni 2: 41-43
Bruce, L.G.; Cuthbert, J.; Ritchie, J.A. 1957: Drug resistant tubercle bacilli in a community. Scottish Medical Journal 2(3): 83-87
Aksenova, V.A.; Luginova, E.F. 2003: Drug resistant tuberculosis in children and adolescents. Problemy Tuberkuleza 1: 25-28
Odigwe, C. 2004: Drug resistant tuberculosis soars in eastern Europe. Bmj 328(7441): 663
Anonymous 2004: Drug resistant tuberculosis: levels are ten times higher in eastern Europe and central Asia. Releve Epidemiologique Hebdomadaire 79(12): 118-120
Katalinić-Janković, V.; Obrovac, M.; Simunović, A. 2004: Drug resistant tuberculosis: ten years of surveillance in Croatia. Acta medica Croatica: casopis Hravatske akademije medicinskih znanosti 58(4): 269-273
Gupta, P.P.; Agarwal, D. 2005: Drug resistant tuberculous osteomyelitis of small bones of foot. Journal of the Association of Physicians of India 53: 725-727
Ebenezer, G.J.; Norman, G.; Joseph, G.A.; Daniel, S.; Job, C.K. 2002: Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India. Indian Journal of Leprosy 74(4): 301-312
Tanaka, Y.; Sato, K.; Yamato, M.; Okano, T.; Kitamori, T. 2004: Drug response assay system in a microchip using human hepatoma cells. Analytical Sciences: the International Journal of the Japan Society for Analytical Chemistry 20(3): 411-413
Young, D. 2006: Drug risks and benefits poorly communicated, experts contend. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(14): 1312; 1314
Waller, P.C.; Evans, S.J.W.; Beard, K. 2005: Drug safety and regulation. Bmj 331(7507): 4-5
Joch, A. 2003: Drug safety for the long-term. Long-term care facilities have the same medication management concerns as hospitals, plus others. Healthcare Informatics: the Business Magazine for Information and Communication Systems 20(7): 38
Orser, B.A.; Dionee, C.; Hyland, S. 2006: Drug safety in Canada: 2 steps forward, 1 step back. Cmaj: Canadian Medical Association Journal 174(1): 66; Discussion: 66-67
McMurray, J.J.V. 2006: Drug safety in cardiovascular disease: a call to ACTION. Cardiovascular Drugs and Therapy 20(1): 9-10
Juurlink, D.N.; Hansten, P.D. 2005: Drug safety in patients with heart failure. Archives of Internal Medicine 165(1): 118
Ruck, B.; Marcus, S.; Kashani, J.; Vassilev, Z. 2006: Drug safety monitoring. JAMA 296(13): 1590; Author Reply 1590
Herdegen, T.; Fauler, J. 2006: Drug safety of NSAIDs and COX-2 inhibitors. Medizinische Monatsschrift für Pharmazeuten 29(4): 122-128
Finkelstein, J.B. 2006: Drug safety system needs overhaul, experts say. Journal of the National Cancer Institute 98(6): 379-381
Edlavitch, S.A.; Salmon, J.W. 2006: Drug safety within drug use. Disease Management: Dm 9(5): 259-265
Bachtold, D. 2003: Drug safety. Conflict-of-interest allegations derail inquiry into antidepressant's 'dark side'. Science 300(5616): 33
Couzin, J. 2005: Drug safety. FDA panel urges caution on many anti-inflammatory drugs. Science 307(5713): 1183-1185
Couzin, J. 2005: Drug safety. Gaps in the safety net. Science 307(5707): 196-198
Stokstad, E. 2004: Drug safety. IOM recommends action on dietary supplements. Science 304(5668): 188
Moreno Alvarez, P.J.; Madurga Sanz, M. 2003: Drug safety. Notes about surveillance. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 27(1): 60-63
Moreno Alvarez, P.J.; Madurga Sanz, M. 2003: Drug safety. Notes regarding drug surveillance. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 27(5): 331-335
Valverde Merino, M.P.; Otero López, M.J.; Moreno Alvarez, P.J. 2003: Drug safety. Preventing medication errors. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 27(2): 121-126
Couzin, J. 2004: Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 306(5695): 384-385
Furberg, C.D. 1998: Drug safety: the different perspectives. Evidence-Based Cardiovascular Medicine 2(1): 1-2
Pitt, B. 2007: Drug safety: who is responsible?. International Journal of Clinical Practice 61(2): 182-184
Abelson, R. 2003: Drug sales bring huge profits, and scrutiny, to cancer doctors: insurers and experts see high costs and conflicts. New York Times on the Web 2003: A1, 18
Garattini, S.; Garattini, L. 2003: Drug sales in four European countries still differ. Bmj 327(7428): 1404-1405
Thawani, V. 2001: Drug samples are meant for advertising. Issues in Medical Ethics 9(3): 91
Taylor, M. 2005: Drug samples bring scrutiny. Modern Healthcare 35(18): 22
Freeman, J. 2005: Drug samples--there is no free lunch! Minimize your risks and meet your regulatory responsibilities. Iowa Medicine: Journal of the Iowa Medical Society 95(5): 10-11
Burkhart, C.G. 2002: Drug samples: friend or foe?. Journal of Drugs in Dermatology: Jdd 1(2): 123-124
Helseth, V.; Lykke-Enger, T.; Aamo, T.O.; Johnsen, J. 2005: Drug screening among patients aged 17-40 admitted with psychosis. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 125(9): 1178-1180
Schütz, H.; Pain, A.; Erdmann, F.; Verhoff, M.A.; Weiler, G.ün. 2006: Drug screening in urine--common pitfalls in measurement and interpretation. Archiv für Kriminologie 217(1-2): 1-9
Tian, R.; Yu, L.-y.; Xiao, C.-l.; Zuo, L.; Yao, T.-j.; Yang, L.-x. 2004: Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 26(4): 359-363
Cherkes, J.K. 2006: Drug screening: adjunct to the differential diagnosis of drug intoxication. Medicine and Health Rhode Island 89(11): 377-378
Friese, G.; Wojciehoski, R.F.; Friese, A. 2005: Drug seekers: do you recognize the signs?. Emergency Medical Services 34(10): 64-67; 88-89
Hamdan, H. 2003: Drug selection for dental postoperative pain control in adults. Northwest Dentistry 82(3): 36-39
Davis, B.M.; Reese, J.S.; Lingas, K.; Gerson, S.L. 2003: Drug selection of mutant methylguanine methyltransferase from different oncoretroviral backbones results in multilineage hematopoietic transgene expression in primary and secondary recipients. Journal of HematoTherapy and Stem Cell Research 12(4): 375-387
Steinman, K.J. 2005: Drug selling among high school students: related risk behaviors and psychosocial characteristics. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 36(1): 71.E1-71.E8
Theodore, F.H. 1952: Drug sensitivities and irritations. American Journal of Ophthalmology 35(10): 1504-1505
Theodore, F.H. 1953: Drug sensitivities and irritations of the conjunctiva. Journal of the American Medical Association 151(1): 25-30
Lecomte, J. 1958: Drug sensitivities; their significance in medical pathology. Revue Medicale de Liege 13(19): 660-672 Contd
Hashimoto, K.; Kinosita, C.; Yoshinaga, H.; Sonda, Y.; Itoyama, T.; Oyamada, K.; Kajimura, K.; Kondou, M.; Sagawa, K.; Ouno, T.; Kawamoto, K.; Souda, K.; Hara, K.; Kakihara, M.; Tanaka, T.; Ryutou, M.; Shichiji, A.; Nakashima, K.; Ishibashi, K.; Tabira, R.; Yamamoto, S.; Nishida, M.; Tsutsumi, Y. 2002: Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000. Japanese Journal of Antibiotics 55 Suppl A: 86-94
Tepsiri, N.; Chaturat, L.; Sripa, B.; Namwat, W.; Wongkham, S.; Bhudhisawasdi, V.; Tassaneeyakul, W. 2005: Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines. World Journal of Gastroenterology 11(18): 2748-2753
Nakamura, T.; Takahashi, H. 2004: Drug sensitivity and teicoplanin resistance of coagulase-negative Staphylococcus isolated from blood culture. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 78(1): 46-53
Szybalski, W.; Szybalska, E.H. 1962: Drug sensitivity as a genetic marker for human cell lines. Medical Bulletin 28: 277-293
Ohri, S.K.; Ohri, B.B. 1962: Drug sensitivity in urinary tract infections. Journal of the Indian Medical Association 39: 245-248
Piekarska, K.; Ławrynowicz-Paciorek, M.; Magdziak, A.; Bareja, E.; Rudecka, A.; Wyrebiak, A.; Pietrzyk, M.; Kochman, M. 2002: Drug sensitivity of Enterococcus sp. strains isolated from clinical material or from healthy persons. Medycyna Doswiadczalna i Mikrobiologia 54(4): 305-315
Solov'ev, V.A. 1962: Drug sensitivity of mycobacteria tuberculosis in osteoarticular tuberculosis. Problemy Tuberkuleza 40(2): 91-93
Maekawa, M. 1961: Drug sensitivity of the uterus isolated in chronic experimental fluorosis. Nagasaki Igakkai Zasshi 36: 394-399
Kortekangas, A.E.; Levanto, A. 1955: Drug sensitivity of tubercle bacilli; comparison of three different methods. Annales Medicinae Experimentalis et Biologiae Fenniae 33(1-2): 12-22
Kortekangas, A.E. 1954: Drug sensitivity of tubercle bacilli; the influence of specific therapy upon it. Annales Chirurgiae et Gynaecologiae Fenniae. Suppl 43(5): 154-160
Shman, T.V.; Belevtsev, M.V.; Buglova, S.E. 2005: Drug sensitivity of tumor cells in varieties of acute childhood leukemia. Voprosy Onkologii 51(5): 558-562
Fukuyama, M.; Oonaka, K.; Furuhata, K.; Hara, M.; Nakazawa, M. 2005: Drug sensitivity of vero toxin-producing Escherichia coli O157:H7 (VTEC O157:H7) isolated from human diarrhea and healthy cows. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 79(7): 451-456
Lecomte, J. 1954: Drug sensitization. Revue Medicale de Liege 9(13): 397-401
Koester, S.; Glanz, J.; Barón, A. 2005: Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention. Aids and Behavior 9(1): 27-39
Heyder, D.W. 1960: Drug shock therapy. Preliminary report on ditran (JB 329). Virginia Medical Monthly 87: 440-441
Jung, F. 1953: Drug shortage in the German Democratic Republic. Die Pharmazie 8(1): 101-102
Frankish, H. 2006: Drug shows potential for treatment of Huntington's disease. Lancet. Neurology 5(6): 476-477
Kuehn, B.M. 2006: Drug shows promise for marfan syndrome. JAMA 295(17): 1990
Frankish, H. 2006: Drug shows promise for treatment of Alzheimer's disease. Lancet. Neurology 5(4): 300
Berkhov, T.M. 1959: Drug sickness caused by the use of PAS. Sovetskaia Meditsina 23: 126-127
Hergan, K.; Kofler, K.; Oser, W. 2004: Drug smuggling by body packing: what radiologists should know about it. European Radiology 14(4): 736-742
Rodriguez-Perez, A.I.; Rodriguez-Tenreiro, C.; Alvarez-Lorenzo, C.; Concheiro, A.; Torres-Labandeira, J.J. 2006: Drug solubilization and delivery from cyclodextrin-Pluronic aggregates. Journal of Nanoscience and Nanotechnology 6(9-10): 3179-3186
Williams, B. 2003: Drug specific benefits and cardiovascular and stroke outcomes. Journal of Hypertension 21(9): 1609-1610
Jaeger, K.D. 2005: Drug spending. Health Affairs 24(1): 297; Author Reply 297
Kondro, W. 2006: Drug spending hits 24.8 billion dollars. Cmaj: Canadian Medical Association Journal 175(1): 22
Morgan, S. 2004: Drug spending in Canada: recent trends and causes. Medical Care 42(7): 635-642
Moynihan, R. 2004: Drug spending in North America rose by 11% in 2003. Bmj 328(7442): 727
Alvarez, J.-C.; De Mazancourt, P.; Chartier-Kastler, E.; Denys, P. 2004: Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture. Journal of Pain and Symptom Management 28(3): 268-272
Sanchez, M. 2006: Drug substitution treatment in clinical practice. Presse Medicale 35(7-8): 1111-1112
Anonymous 2005: Drug success signals a new trend. A "race-based" medication is a step toward individualized care. Heart Advisor 8(4): 4-5
Hoch, J.H. 1961: Drug supply and blockade runners, 1861-65. Journal of the South Carolina Medical Association 57: 257-260
Copeman, M. 2003: Drug supply and drug abuse. Cmaj: Canadian Medical Association Journal 168(9): 1113; Author Reply 1113
Libaudière, C.; Sibille, B.; Bakala, N.; Tran-Minh, T.; Mouala, C.; Adam, G.; Mattei, J.F. 2006: Drug supply for HIV patients in day care centre in Republic of Congo: the French Red Cross experience. Medecine Tropicale: Revue du Corps de Sante Colonial 66(6): 598-601
Schulze-Manitius, H. 1959: Drug supply in emergencies-discovery of photography by carrier pigeons. Pharmazeutische Praxis 7: 92-93
Isacson, L. 1960: Drug supply in the limelight. Some impressions on the suggestions submitted by the Drug Committee. Svensk Farmaceutisk Tidskrift 64: 93-97
Brans, P.H. 1963: Drug supply of the Admiralty and in the East Indian campaign. Pharmaceutisch Weekblad 98: 596-608
Yusuff, K.B.; Tayo, F. 2004: Drug supply strategies, constraints and prospects in Nigeria. African Journal of Medicine and Medical Sciences 33(4): 389-394
Oliva Bolzoni, M.; Perari, D.; Monesi, G. 2002: An area-wide survey of problems of domiciliary care of diabetic patients. Assistenza Infermieristica e Ricerca: Air 21(4): 178-183
Mulherin, D.; Wong, M. 2006: Drug survival in rheumatoid arthritis. Rheumatology 45(9): 1178; Author Reply 1178-9
Lewin, E.; Hirsch, J.G. 1955: Drug susceptibilities of M. tuberculosis on charcoal agar medium. American Review of Tuberculosis 71(3 Part 1): 447-451
Gordon, F.B.; Quan, A.L. 1962: Drug susceptibilities of the psittacosis and trachoma agents. Annals of the new York Academy of Sciences 98: 261-274
Okuno, R.; Endoh, M.; Shimojima, Y.; Yanagawa, Y.; Morozumi, S.; Oonaka, K.; Furuhata, K.; Fukuyama, M. 2005: Drug susceptibility and analysis using pulsed-field gel electrophoresis of Streptococcus pyogenes strains isolated from the patients with streptococcal toxic shock syndrome (STSS) in Japan. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 79(4): 260-269
Parreiras, P.íc.M.; Lobato, F.C.F.; Alencar, A.éa.P.; Figueiredo, T.d.; Gomes, H.M.; Boéchat, N.; Lage, A.P.; Assis, R.A.; Pereira, M.ár.A.S.; Souza, P.íc.R.; Mota, P.M.P.C.; Suffys, P.N. 2004: Drug susceptibility of Brazilian strains of Mycobacterium bovis using traditional and molecular techniques. Memorias do Instituto Oswaldo Cruz 99(7): 749-752
Eyob, G.; Guebrexabher, H.; Lemma, E.; Wolday, D.; Gebeyehu, M.; Abate, G.; Rigouts, L.; van Soolingen, D.; Fontanet, A.; Sanders, E.; Dorigo-Zetsma, J.W. 2004: Drug susceptibility of Mycobacterium tuberculosis in HIV-infected and -uninfected Ethiopians and its impact on outcome after 24 months of follow-up. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 8(11): 1388-1391
Kaddouri, H.; Jafari, S.; Durand, R.ém.; Le Bras, J. 2004: Drug susceptibility of Plasmodium falciparum from polyclonal isolates. Journal de la Societe de Biologie 198(3): 199-206
Pszenna, M.ła.; Rokosz, A.; Luczak, M.ła. 2005: Drug susceptibility of Pseudomonas aeruginosa strains isolated from patients of a hospital and specialistic outpatients clinics of the SP ZOZ in Nidzica. Medycyna Doswiadczalna i Mikrobiologia 57(3): 303-310
Kouda, M.; Matsushima, H.; Homma, S.; Marumo, K.; Komine, Y.; Iizuka, T. 2003: Drug susceptibility of Trichosporon beigelii isolated from urine and clinical features of their hosts. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 77(7): 480-487
Hsu, S.Y.; Chu, K.Y.; Hsu, H.F. 1963: Drug susceptibility of geographic strains of Schistosoma japonicum. Zeitschrift für Tropenmedizin und Parasitologie 14: 37-40
Stamm, W. 1962: Drug susceptibility of hypoxic fatigue state of smooth muscles. Helvetica Physiologica et Pharmacologica Acta 20: 206-211
Kusachi, S.; Sumiyama, Y.; Nagao, J.; Arima, Y.; Yoshida, Y.; Tanaka, H.; Nakamura, Y.; Saida, Y.; Watanabe, M.; Sato, J. 2005: Drug susceptibility of isolates from severe postoperative intraperitoneal infections causing multiple organ failure. Surgery Today 35(2): 126-130
Lwai-Lume, L.; Ogutu, E.O.; Amayo, E.O.; Kariuki, S. 2005: Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi. East African Medical Journal 82(12): 603-608
Johansen, I.S.; Larsen, A.R.; Sandven, P.; Petrini, B.; Soini, H.; Levina, K.; Sosnovskaja, A.; Skenders, G.; Hoffner, S. 2003: Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic-Baltic collaboration. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 7(9): 899-902
Macris, S.G.; Gravenstein, J.S.; Reichle, C.W.; Beecher, H.K. 1958: Drug synergism (potentiation) in pain relief in man: papaverine and morphine. Science 128(3315): 84-85
Ford, R.A.; Blanchard, K. 1958: Drug synergism in the management of arthritides. Journal-Lancet 78(5): 185-189
Buechi, J.; Fueeg, H. 1960: Drug synthesis studies on sulfones. Archiv der Pharmazie und Berichte der Deutschen Pharmazeutischen Gesellschaft 293-65: 283-295
Amoako, D.; Lavies, N.G. 2003: Drug syringe labelling--does complacency come with age?. Anaesthesia 58(8): 816
Sengupta, S.; Thomas, S.A. 2006: Drug target interaction of tubulin-binding drugs in cancer therapy. Expert Review of Anticancer Therapy 6(10): 1433-1447
Sanz-González, S.M.; Cano, A.; Valverde, M.A.; Hermenegildo, C.; Andrés, V. 2004: Drug targeting of estrogen receptor signaling in the cardiovascular system: preclinical and clinical studies. Current Medicinal Chemistry. Cardiovascular and Hematological Agents 2(2): 107-122
Hurley, L.H.; Von Hoff, D.D.; Siddiqui-Jain, A.; Yang, D. 2006: Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element. Seminars in Oncology 33(4): 498-512
Sachdeva, M.S. 1998: Drug targeting systems for cancer chemotherapy. Expert Opinion on Investigational Drugs 7(11): 1849-1864
Yokoyama, M. 2005: Drug targeting with nano-sized carrier systems. Journal of Artificial Organs: the Official Journal of the Japanese Society for Artificial Organs 8(2): 77-84
Venezia, P. 2005: Drug targets in colonoscopic polypectomy: biological sealants with special reference to fibrin-glue (tissucol). Current Drug Targets. Immune Endocrine and Metabolic Disorders 5(3): 339-345
Covelli, V.; Passeri, M.E.; Leogrande, D.; Jirillo, E.; Amati, L. 2005: Drug targets in stress-related disorders. Current Medicinal Chemistry 12(15): 1801-1809
Triggle, D.J. 2003: Drug targets in the voltage-gated calcium channel family: why some are and some are not. Assay and Drug Development Technologies 1(5): 719-733
Ranieri, G.; Ruggieri, E.; Falco, G.; Zizzo, N.; Mattioli, E.; Zito, A.Francesco.; Patruno, R.; Gasparini, G. 2006: Drug targets to pro-angiogenetic factors with special reference to primary peritoneal mesothelioma. Endocrine Metabolic and Immune Disorders Drug Targets 6(3): 271-277
Mikkelsen, J.D. 2005: Drug targets: identification and evaluation. Ugeskrift for Laeger 167(20): 2156-2160
Sandstrom, D.J.; Nash, H. 2004: Drug targets: turning the channel (on) for sedation. Current Biology: Cb 14(5): R185-R186
Daghfous, R.; El Aidli, S.; Gheni, R.; Belkahia, C. 2005: Drug tendon disorders. La Tunisie Medicale 83(5): 253-257
White, T. 2003: Drug testing at work: issues and perspectives. Substance use and Misuse 38(11-13): 1891-1902
Barlament, J.L. 2004: Drug testing for multiemployer plans: choosing the proper legal structure. Employee Benefits Journal 29(1): 51-55
Lustgarten, A. 2005: Drug testing goes offshore. Fortune 152(3): 66-70; 72
Larcan, A. 1962: Drug testing in France. Münchener Medizinische Wochenschrift 104: 1624-1627
Drummer, O.H. 2006: Drug testing in oral fluid. Clinical Biochemist. Reviews 27(3): 147-159
Mao, Z-Guang.; Jiang, Y-Wu.; Mao, J-Hua.; Tong, P-Jian. 2016: Application of 3D printing technology in the complex acetabular prosthesis revision surgery:a case report. Zhongguo Gu Shang 29(11): 1058-1060
Blaze-Temple, D. 1992: Drug testing in the Australian workplace: overview of the issues. Drug and Alcohol Review 11(1): 59-73
Ulianowa, G.A. 1962: Drug testing in the USSR. Münchener Medizinische Wochenschrift 104: 1628-1630
Wolff, F. 1962: Drug testing in the United States. Münchener Medizinische Wochenschrift 104: 1630-1632
Levy, S.; Harris, S.K.; Sherritt, L.; Angulo, M.; Knight, J.R. 2006: Drug testing of adolescents in general medical clinics, in school and at home: physician attitudes and practices. Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 38(4): 336-342
Mieczkowski, T. 2004: Drug testing the police: some results of urinalysis and hair analysis in a major US metropolitan police force. Journal of Clinical Forensic Medicine 11(3): 115-122
Couzin, J. 2005: Drug testing. Massive trial of Celebrex seeks to settle safety concerns. Science 310(5756): 1890-1891
Couzin, J. 2004: Drug testing. Regulators talk up plans for drug biomarkers .. Science 306(5699): 1119
Franceschi, A.; Tuccori, M.; Bocci, G.; Vannozzi, F.; Di Paolo, A.; Barbara, C.; Lastella, M.; Blandizzi, C.; Del Tacca, M. 2004: Drug therapeutic failures in emergency department patients. A university hospital experience. Pharmacological Research 49(1): 85-91
Taneja, S.S. 2005: Drug therapies for eradicating high-grade prostatic intraepithelial neoplasia in the prevention of prostate cancer. Reviews in Urology 7 Suppl. 3: S19-S29
Noseda, A. 2003: Drug therapies of COPD. Revue Medicale de Bruxelles 24(4): A354-A357
Kovanen, P.T.; Mäyranpää, M.; Lindstedt, K.A. 2005: Drug therapies to prevent coronary plaque rupture and erosion: present and future. Handbook of Experimental Pharmacology 2005(170): 745-776
Moyer, J.H. 1955: Drug therapy (Rauwolfia) of hypertension. I. Pharmacodynamics of Rauwolfia. A.M.A. Archives of Internal Medicine 96(4): 518-529
Moyer, J.H.; Dennis, E.; Ford, R. 1955: Drug therapy (Rauwolfia) of hypertension. II. a comparative study of different extracts of Rauwolfia when each is used alone (orally) for therapy of ambulatory patients with hypertension. A.M.A. Archives of Internal Medicine 96(4): 530-543
Caplovitz, C.; Conner, P.K.; Dennis, E.; Ford, R.; Hershberger, R.; Kinard, S.; Mcconn, R.; Moyer, J.H. 1956: Drug therapy (mecamylamine) of hypertension. III. Results with mecamylamine, a completely absorbed ganglionic blocking agent. A.M.A. Archives of Internal Medicine 98(2): 187-210
Terént, A. 2003: Drug therapy after stroke should be evidence-based. Organizational, economic and ethical decisions direct the choice of treatment. Lakartidningen 100(47): 3860-3864; 3866
Iwatsubo, K.; Okumura, S.; Ishikawa, Y. 2006: Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signaling. Endocrine Metabolic and Immune Disorders Drug Targets 6(3): 239-247
Hambrecht, R. 2003: Drug therapy and adjuvant therapy in heart failure. Exercise training--more effective than digitalis?. MMW Fortschritte der Medizin 145(17): 30-33
Jauhar, S.; Chinitz, L.; Jorde, U.; Cohen, R.J. 2003: Drug therapy and microvolt T-wave alternans testing. Lancet 362(9393): 1417-8; Author Reply 1418
Verkasalo, M. 2003: Drug therapy and nutrition therapy of a young patient with Crohn disease. Duodecim; Laaketieteellinen Aikakauskirja 119(7): 617-624
Müller-Zellenberg, U.; Müller, M. 2005: Drug therapy and pharmacogenomics--hopes and facts. Wiener Medizinische Wochenschrift 155(3-4): 45-49
Kato, T. 2004: Drug therapy and psychotherapy for the treatment of bipolar disorders. Seishin Shinkeigaku Zasshi 106(5): 587-590
Eroshevskii, T.I. 1957: Drug therapy and surgery in glaucoma; review of foreign literature. Vestnik Oftalmologii 70(4): 7-23
Stoica, O.; Braha, E.; Ungureanu, G. 2002: Drug therapy at the beginning of the genomic era. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 107(2): 240-246
Blalock, S.J.; Patel, R.A. 2005: Drug therapy concerns questionnaire: initial development and refinement. Journal of the American Pharmacists Association: Japha 45(2): 160-169
Curtiss, F.R. 2002: Drug therapy customized to individual patients. Journal of Managed Care Pharmacy: Jmcp 8(4): 296-297
Rowe, G.C. 1959: Drug therapy during cardiac arrest. Wisconsin Medical Journal 58: 663-665
Briggs, G.G.; Wan, S.R. 2006: Drug therapy during labor and delivery, part 1. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(11): 1038-1047
Briggs, G.G.; Wan, S.R. 2006: Drug therapy during labor and delivery, part 2. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(12): 1131-1139
Savonitto, S.; Ambrosini, V.; Marzocchi, A.; Tolaro, S.; Petronio, A.S.; Galassi, A.R.; Bongo, A.S.; Gaglione, A.; Bolognese, L. 2005: Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 106-118
Silva Castro, M.M.; Calleja Hernández, M.A.; Tuneu i Valls, L.; Fuentes Caparrós, B.; Gutiérrez Sáinz, J.; Faus Dader, M.J. 2004: Drug therapy follow-up in patients admitted to a Surgery Department. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 28(3): 154-169
Kavanagh, S.; Kabathova, P. 2004: Drug therapy for Alzheimer's disease. Cmaj: Canadian Medical Association Journal 170(9): 1371-2; Author Reply 1372-4
Kudo, T. 2004: Drug therapy for aged patients with Alzheimer disease. Seishin Shinkeigaku Zasshi 106(1): 62-67
Horiguchi, J. 2005: Drug therapy for aged patients with psychosomatic symptoms. Seishin Shinkeigaku Zasshi 107(4): 389-397
Carter, G.T.; Krivickas, L.S.; Weydt, P.; Weiss, M.D.; Miller, R.G. 2003: Drug therapy for amyotrophic lateral sclerosis: Where are we now?. Idrugs: the Investigational Drugs Journal 6(2): 147-153
Jackson, K.C.; Lipman, A.G. 2004: Drug therapy for anxiety in palliative care. Cochrane Database of Systematic Reviews 1: Cd004596
Dees, S.C. 1949: Drug therapy for asthmatic children. North Carolina Medical Journal 10(12): 634-638
Hazell, P. 2007: Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. Journal of Paediatrics and Child Health 43(1-2): 19-24
Anton, H.A.; Townson, A. 2004: Drug therapy for autonomic dysreflexia. Cmaj: Canadian Medical Association Journal 170(8): 1210; Author Reply 1210
Berges, R.; Höfner, K. 2005: Drug therapy for benign prostatic hyperplasia. Systematic overview. Der Urologe. Ausg. a 44(5): 505-512
Calandruccio, R.A.; Edmonson, A.S. 1957: Drug therapy for causalgia. Mississippi Doctor 34(9): 239-241
Livingston, S. 1957: Drug therapy for childhood epilepsy. Journal of Chronic Diseases 6(1): 46-80
Vrancken, A.F.J.E.; van Schaik, I.N.; Hughes, R.A.C.; Notermans, N.C. 2004: Drug therapy for chronic idiopathic axonal polyneuropathy. Cochrane Database of Systematic Reviews 2: Cd003456
Murcia López, A.; Borrás Blasco, J.; Alvarado Valero, M.C.; Navarro Ruiz, A.; González Delgado, M.; Martínez Toldos, J.J. 2005: Drug therapy for corneo-conjunctival neoplasm. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 29(2): 126-133
Jackson, K.C.; Lipman, A.G. 2004: Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews 2: Cd004770
Vuylsteek, K. 1956: Drug therapy for essential hypertension. Belgisch Tijdschrift Voor Geneeskunde 12(11): 599-610
Kuwajima, I. 2003: Drug therapy for hypertension associated with stroke--special reference to the prevention of recurrence. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 92(2): 270-275
Hörl, M.P.; Tepel, M. 2005: Drug therapy for hypertension in hemodialysis patients. Minerva Medica 96(4): 277-285
Wilkins, R.W. 1957: Drug therapy for hypertensive vascular disease in patients past midlife. Geriatrics 12(5): 311-316
Yamanaka, H. 2003: Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 1): 202-208
Mönnikes, H.; Schmidtmann, M.; van der Voort, I.R. 2006: Drug therapy for irritable bowel syndrome. what works, what doesn't work and for whom?. Der Internist 47(10): 1073-1076; 1078-1083
Kikuth, W. 1956: Drug therapy for malaria. Münchener Medizinische Wochenschrift 98(20): 722-727
Tefferi, A.; Letendre, L. 2006: Drug therapy for myelodysplastic syndrome: building evidence for action. Cancer 106(8): 1650-1652
Tomita, K.; Hibi, T. 2006: Drug therapy for non-alcoholic steatohepatitis. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1146-1151
Shen, W. 2003: Drug therapy for nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 11(2): 114
Hingorani, M. 1998: Drug therapy for ocular allergy. Expert Opinion on Investigational Drugs 7(1): 27-55
Kimura, K.; Kosuge, M. 2004: Drug therapy for patients with unstable angina. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 93(2): 271-278
Mitka, M. 2006: Drug therapy for prehypertension questioned. JAMA 296(23): 2787-2788
Ringe, J.D. 2006: Drug therapy for prevention of falls and fractures. Medizinische Klinik 101 Suppl. 1: 1-5
van der Elst, M.E.; Buurma, H.; Bouvy, M.L.; de Boer, A. 2003: Drug therapy for prevention of recurrent myocardial infarction. Annals of PharmacoTherapy 37(10): 1465-1477
Iwasaki, K. 2006: Drug therapy for psychological symptoms of dementia--comparison between western and oriental medicine. Fukuoka Igaku Zasshi 97(3): 53-54
Mehta, S. 2003: Drug therapy for pulmonary arterial hypertension: what's on the menu today?. Chest 124(6): 2045-2049
Wang, N.; Fan, Z.; Wu, H.; Li, D.; Huang, Y.; Chen, J.; Lin, H. 2002: Drug therapy for residual angle-closure glaucoma after laser iridectomy. Chinese Journal of Ophthalmology 38(12): 712-716
Ullmann, K. 1956: Drug therapy for skeletal tuberculosis. Ergebnisse der Gesamten Tuberkuloseforschung 13: 237-258
Jeske, A.H.; Servos, T.A. 2005: Drug therapy for smoking cessation: evidence-based considerations for dentistry. Texas Dental Journal 122(6): 546-555
Cintas, P. 2006: Drug therapy for symptomatic relief in amyotrophic lateral sclerosis. Revue Neurologique (Paris) 162(Special Issue 2): 4s235-4s243
Talajic, M.; Roy, D. 2005: Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm. Canadian Journal of Cardiology 21 Suppl B: 19b-25b
Weinberg, H.B. 1957: Drug therapy for the emotionally and mentally disturbed; the internist's point of view. JOURNAL. Iowa State Medical Society 47(1): 17-19
Graves, C.C. 1957: Drug therapy for the emotionally and mentally disturbed; the psychiatrist's point of view. JOURNAL. Iowa State Medical Society 47(1): 15-16
McClain, K.L. 2005: Drug therapy for the treatment of Langerhans cell histiocytosis. Expert Opinion on PharmacoTherapy 6(14): 2435-2441
Brucke, F. 1949: Drug therapy for tuberculosis. Wiener Klinische Wochenschrift 61(39): 623-626
Brugger, H. 1956: Drug therapy for tuberculosis of the peripheral lymph nodes. Ergebnisse der Gesamten Tuberkuloseforschung 13: 411-435
Jo, Y.; Matsumoto, T.; Iida, M. 2005: Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(5): 820-824
Hirashima, N. 2004: Drug therapy from the viewpoint of dynamic psychotherapy. Seishin Shinkeigaku Zasshi 106(5): 591-594
Márquez, M.F.; Salica, G.; Hermosillo, A.G.; Pastelín, G.; Cárdenas, M. 2005: Drug therapy in Brugada syndrome. Current Drug Targets. Cardiovascular and Haematological Disorders 5(5): 409-417
Wainberg, M.A. 1999: Drug therapy in HIV infection--fourth international congress. 8-12 November 1998, Glasgow, Scotland. IDrugs: the investigational drugs journal 2(1): 18-19
Van Deinse, J.B. 1953: Drug therapy in Menière's disease. Monatsschrift für Ohrenheilkunde und Laryngo-Rhinologie 87(1): 41-43
Freeman, J.T. 1963: Drug therapy in aging patients. Geriatrics 18: 174-180
Hinnant, I.M. 1951: Drug therapy in allergic disease. Journal of the South Carolina Medical Association 47(11): 401-406
Gottlieb, P.M. 1961: Drug therapy in allergic states. Pennsylvania Medical Journal 64: 489-491
Erdman, W.J.; Piersol, G.M. 1956: Drug therapy in ambulatory hemiplegia and degenerative joint disease. Industrial Medicine and Surgery 25(10): 495
Neye, H.; Breitkreutz, J.ör. 2004: Drug therapy in and childhood and old age. Medizinische Monatsschrift für Pharmazeuten 27(5): 161-167
Freedman, A.M. 1958: Drug therapy in behavior disorders. Pediatric Clinics of North America 5(3): 573-594
Mautner, H. 1956: Drug therapy in cerebral palsy. Archives of Pediatrics 73(10): 351-381
Fish, B. 1960: Drug therapy in child psychiatry: pharmacological aspects. Comprehensive Psychiatry 1: 212-227
Fish, B. 1960: Drug therapy in child psychiatry: psychological aspects. Comprehensive Psychiatry 1: 55-61
Brochhausen, C.; Seyberth, Hörg.W. 2003: Drug therapy in childhood and adolescence. A challenge between patient protection and therapy safety. Kinderkrankenschwester: Organ der Sektion Kinderkrankenpflege 22(1): 8-11
Maier, K.-P. 2005: Drug therapy in chronic liver disease. Praxis 94(48): 1907-1912
Yamazaki, Y.; Ohta, T.; Iida, F. 1962: Drug therapy in chronic otitis media resistant to therapy in infants. Jibi Inkoka Otolaryngology 34: 245-246
Von Eisenhart-Rothe, R.; Rittmeister, M. 2004: Drug therapy in complex regional pain syndrome type i. Der Orthopade 33(7): 796-803
Mehta, M. 2006: Drug therapy in congenital methaemoglobinaemia. Anaesthesia and Intensive Care 34(6): 828-829
Becker, D.E. 2006: Drug therapy in dental practice: general principles. Part 1 - Pharmacokinetic considerations. Anesthesia Progress 53(4): 140-145; Quiz 146
Becker, D.E. 2007: Drug therapy in dental practice: general principles. Part 2 - pharmacodynamic considerations. Anesthesia Progress 54(1): 19-23; Quiz: 24-25
Becker, D.E.; Phero, J.C. 2005: Drug therapy in dental practice: nonopioid and opioid analgesics. Anesthesia Progress 52(4): 140-149
Frick, H.C. 1961: Drug therapy in gynecological cancer. Bulletin of the Sloane Hospital for Women in the Columbia-Presbyterian Medical Center new York City 7: 82-86
Doyle, A.E.; Smirk, F.H. 1955: Drug therapy in hypertension; a critical review. Practitioner 174(1040): 135-143
Grollman, A. 1950: Drug therapy in management of neoplastic disease. Texas State Journal of Medicine 46(7): 504-509
Capparell, H.V. 1962: Drug therapy in mental illness. Pennsylvania Medical Journal 65: 899-905
Breitner, C. 1960: Drug therapy in obsessional states and other psychiatric problems. Diseases of the Nervous System 21(3)suppl: 31-35
Chao, D. 1963: Drug therapy in paroxysmal cerebral disorders. Pediatric Clinics of North America 10: 3-15
Gonzalez-Meneses Pardo, A. 1960: Drug therapy in poliomyelitis. Hispalis Medica; Revista Sevillana de Medicina y Cirugia 17: 55-62
Bestehorn, K.; Zink, A.; Dreher, R. 2002: Drug therapy in postmenopausal osteoporosis. An analysis of healty service delivery. Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 96(10): 699-704
Mukhopadhyay, P.; Chowdhury, S. 2005: Drug therapy in prediabetes. Journal of the Indian Medical Association 103(11): 603
Reister, F.; Paulus, W.; Kreienberg, R. 2004: Drug therapy in pregnancy--a practical guide. MMW Fortschritte der Medizin 146(11): 33; 35-37
Mendlowitz, M.; Parets, A.D.; Gold, T.; Drachman, S.R. 1958: Drug therapy in primary hypertension in relation to the severity of the disease. Journal of Chronic Diseases 7(6): 484-492
Davis, W.A.; Severinghaus, E.L. 1956: Drug therapy in psychiatry and neurology; medical and pharmacologic aspects. Journal of the Medical Society of New Jersey 53(1): 18-22
Uranga Imaz, F.A. 1960: Drug therapy in psychoprophylactic labor. El Dia Medico 32: 1723-1724
Kumar, K. 1961: Drug therapy in pulmonary tuberculosis. Journal of the Indian Medical Association 36: 236-241
Masuev, A.M. 1957: Drug therapy in respiratory arrhythmia; clinical and experimental data. Klinicheskaia Meditsina 35(5): 37-42
Casey, J.F.; Bennett, I.F.; Lindley, C.J.; Hollister, L.E.; Gordon, M.H.; Springer, N.N. 1960: Drug therapy in schizophrenia. a controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. A.M.A. Archives of General Psychiatry 2: 210-220
Salvesen, R. 2003: Drug therapy in secondary prophylaxis after transient cerebral ischemia or cerebral infarction. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(20): 2875-2877
Chlenov, L.G.; Serkova, M.P. 1957: Drug therapy in spastic hemiparesis. Klinicheskaia Meditsina 35(5): 32-37
Mopin, F.ço.; Thibault, P. 2003: Drug therapy in temporary child care areas. SOINS. Pediatrie Puericulture 210: 26-32
Von Renteln-Kruse, W. 2005: Drug therapy in the aged. Zeitschrift für Gerontologie und Geriatrie 38(3): 169-172
Morandi, A. 1962: Drug therapy in the course of therapeutic pneumothorax. La Clinica Terapeutica 22: 53-65
Onuaguluchi, G. 1961: Drug therapy in the crises of postencephalitic parkinsonism. Scottish Medical Journal 6: 368-375
Turnheim, K. 2004: Drug therapy in the elderly. Experimental Gerontology 39(11-12): 1731-1738
Wotquenne, P.; Petermans, J.; Scheen, A.J. 2006: Drug therapy in the elderly. what should we know?. Revue Medicale Suisse 2(76): 1878-1880; 1882-1883
Hoffmann, F.; Meyer, F. 2005: Drug therapy in the elderly: limiting to the essentials. Pflege Zeitschrift 58(5): 282-286
Levy, S. 1956: Drug therapy in the emotionally disturbed aged. Northwest Medicine 55(3): 298-300
Kitakaze, M.; Kato, O.; Tsuchikane, E.; Sada, M.; Tsutsui, H.; Komuro, K. 2005: Drug therapy in the era of DES (drug eluting stents)--expectation on angiotensin II receptor blockers (ARB): discussion. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(1): 167-172
Levy, C. 1954: Drug therapy in the management of hypertension. Delaware Medical Journal 26(2): 36-40
Rogers, S.F.; Moyer, J.H.; Hughes, W.M.; Moore, J. 1954: Drug therapy in the management of pregnancy toxemia. Southern Medical Journal 47(9): 871-883
Stengaard, M.; Kruse, P.R. 2004: Drug therapy in the official danish plague instructions, 1619-1709. Theriaca 2004(35): 90-106
Bernardo, J.é F.; McCauley, J. 2004: Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions. Drugs and Aging 21(5): 323-348
Møller, L.Alling.; Abel, I.; Thyssen, H.; Sander, P.; Mouritsen, L.; Lose, G.; Sørensen, C.; Philipsen, J.; Ottesen, M.; Rasmussen, F.Aagård.; Topp, M.; Larsen, J.; Gimbel, H. 2006: Drug therapy in urinary incontinence and/or bladder emptying problems. Ugeskrift for Laeger 168(26-32): 2580
Bowers, J.R.; Dailiana, Z.H.; McCarthy, E.F.; Urbaniak, J.R. 2004: Drug therapy increases bone density in osteonecrosis of the femoral head in canines. Journal of Surgical Orthopaedic Advances 13(4): 210-216
Funk, B.; Kosek, R.; Käser, L.; Vetter, W. 2004: Drug therapy knowledge in ambulatory cardiovascular patients. Praxis 93(37): 1493-1501
McDonough, R.P.; Doucette, W.R. 2003: Drug therapy management: an empirical report of drug therapy problems, pharmacists' interventions, and results of pharmacists' actions. Journal of the American Pharmacists Association: Japha 43(4): 511-518
Skausig, O.Bjørn.; Laugesem, L.P.; Jensen, T. 2003: Drug therapy of Alzheimer dementia. Ugeskrift for Laeger 165(29): 2899; Author Reply 2899-900
Skausig, O.Bjørn. 2004: Drug therapy of Alzheimer disease. Ugeskrift for laeger 166(49): 4497-8; author reply 4498
Fleming, T.C. 1955: Drug therapy of Parkinsonism. Virginia Medical Monthly 82(6): 276-279
Schleipen, C. 1954: Drug therapy of Sudeck's bone atrophy. Die Medizinische 17: 624-625
Letmaier, M.; Schreinzer, D.; Thierry, N.; Wolf, R.; Kasper, S. 2004: Drug therapy of acute manias. A retrospective data analysis of inpatients from 1997 to 1999. Der Nervenarzt 75(3): 249-257
Lameire, N.; Vanholder, R. 2000: Drug therapy of acute renal failure. Idrugs: the Investigational Drugs Journal 3(10): 1206-1216
Ueno, S.; Yoshiga, M.; Hirose, S. 1962: Drug therapy of acute viral hepatitis, with special reference to steroid therapy. Therapy 44: 1843-1851
Salaspuro, M. 2003: Drug therapy of alcohol dependence--a critical review. Duodecim; Laaketieteellinen Aikakauskirja 119(24): 2503-2507
Siegenthaler, W.; Koller, F. 1954: Drug therapy of alcoholism with antabuse. Schweizerische Medizinische Wochenschrift 84(7): 213-217
Roseler, W. 1952: Drug therapy of amenorrhea. El Dia Medico 24(39): 948-949
Abt, E.G. 1955: Drug therapy of arterial hypertension and acute critical hypertensive manifestation by lowering blood pressure with penthonium. Arztliche Forschung 9(8): I/396-I/399
Masek, O. 1955: Drug therapy of arterial hypertension. IIi. Vnitrni Lekarstvi 1(2): 141-145
Rønnov-Jessen, V. 1954: Drug therapy of arterial hypertension; pentapyrrolidinium bitartrate (ansolysen), a new remedy for peroral use. Ugeskrift for Laeger 116(15): 551-558
Rønnov-Jessen, V.; Bech, V. 1953: Drug therapy of arterial hypertension; preliminary report on own experience with hexamethonium. Ugeskrift for laeger 115(16): 589-600
Lian, C. 1957: Drug therapy of arterial spasms and obliterating arteritis. La Presse Medicale 65(66): 1477-1478
Langen, U.; Knopf, H.; Melchert, H-U. 2006: Drug therapy of asthma. Results of the 1998 German National Health Interview and Examination Survey. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 49(9): 903-910
Rauschmann, M.A.; von Stechow, D. 2003: Drug therapy of back pain. Der Orthopade 32(12): 1120-1126
Chuchalin, A.G.; Tsoĭ, A.N.; Arkhipov, V.V. 2003: Drug therapy of bronchial asthma from the point of view of medicines, based on evidence. Terapevticheskii Arkhiv 75(3): 73-77
Deming, J.W. 1958: Drug therapy of cardiac arrhythmia. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 110(9): 299-305
Kless, H.N. 1962: Drug therapy of cardiac edema, with special consideration on the role of natural and synthetic adrenal cortex hormones. Arzneimittel-Forschung 12: 422-426
Garnier, B. 1963: Drug therapy of cerebral circulation disorders. Schweizerische Medizinische Wochenschrift 93: 176-179
Hansen, E. 1961: Drug therapy of cerebral palsy with chlormethazanone. Ugeskrift for Laeger 123: 1353-1354
Feldman, D.J. 1957: Drug therapy of chronic alcoholism. Medical Clinics of North America 41(2): 381-392
Dulin, B.R.; Krum, H. 2006: Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Current Opinion in Cardiology 21(4): 393-399
Román de Jesús, J.C. 2001: Drug therapy of chronic pain in the aged. Boletin de la Asociacion Medica de Puerto Rico 93(1-12): 35-40
Bogdanets, L.I.; Arakelian, V.S.; Sapelkin, S.V.; Kalinina, E.V. 2005: Drug therapy of chronic venous insufficiency with Venza. Angiologiia i Sosudistaia Khirurgiia 11(3): 55-59
Ulrich-Pur, H.; Jech, B.; Scheithauer, W.; Kornek, G.V.; Huber, H. 2002: Drug therapy of colorectal carcinoma. Wiener Klinische Wochenschrift 114(10-11): 368-376
Oteo-Alvaro, A.; Pérez-Caballer, A.; Gómez-Castresana, F. 2004: Drug therapy of complex regional painful syndrome of the limbs as the cause of neuropathic pain. Revista Clinica Espanola 204(9): 486-494
Böger, G.I.; Hoopmann, M.; Busse, R.; Budinger, M.; Welte, T.; Böger, R.H. 2003: Drug therapy of coronary heart disease--are therapeutic guidelines being paid attention to?. Zeitschrift für Kardiologie 92(6): 466-475
Ranhoff, A.H. 2004: Drug therapy of delirium in the elderly. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 124(23): 3072-3074
Olsen, C.Emil.; Poulsen, H.Day.; Lublin, H.K.F. 2005: Drug therapy of dementia in elderly patients. A review. Nordic Journal of Psychiatry 59(2): 71-77
Nakamura, S. 2005: Drug therapy of dementia: from the viewpoint of internal medicine. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 94(8): 1521-1528
Ikeda, M. 2005: Drug therapy of dementia: from the viewpoint of psychiatry. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 94(8): 1529-1535
de MACEDO 1959: Drug therapy of depressions. Clinical observations with iproniazid. Hospital (Rio de Janeiro) 56: 1053-1058
Wehling, M.; Peiter, A. 2003: Drug therapy of elderly patients from the viewpoint of the clinical pharmacologist. Der Internist 44(8): 1003-1009
Flugel, F. 1959: Drug therapy of endogenous psychoses. Der Nervenarzt 30(6): 241-245
Dimarco, A. 1949: Drug therapy of enteric diseases in mice. Il Farmaco Scienza e Tecnica 4(5): 539-549
Herrlin, K.M. 1954: Drug therapy of epilepsy in childhood. Svenska Lakartidningen 51(44): 2774-2786
Shteinberg, S.M. 1957: Drug therapy of epilepsy; review of foreign literature published during 1956. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 57(6): 781-788
Kajtor, F. 1959: Drug therapy of epileptics. Orvosi Hetilap 100(1): 25-30
Schultheiss, D.; Stief, C.G. 2003: Drug therapy of erectile dysfunction--the current status. Der Urologe. Ausg. a 42(10): 1322-1329
Rosenau, H.J. 1961: Drug therapy of esophageal burns. Das Deutsche Gesundheitswesen 16: 53-55
Geelmuyden, C. 1954: Drug therapy of extrapyramidal diseases. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 74(1): 7-10
Hampel, C.; Gillitzer, R.; Pahernik, S.; Melchior, S.W.; Thüroff, J.W. 2005: Drug therapy of female urinary incontinence. Der Urologe. Ausg. a 44(3): 244-255
Allain, H.é; Bentué-Ferrer, D.èl.; Tribut, O.; Mérienne, M.; Belliard, S. 2003: Drug therapy of frontotemporal dementia. Human Psychopharmacology 18(3): 221-225
Roth, K. 1956: Drug therapy of gastric and duodenal ulcers. Therapie der Gegenwart 95(5): 185-187
Färkkilä, M. 2003: Drug therapy of hepatitis B and C. Duodecim; Laaketieteellinen Aikakauskirja 119(6): 519-529
Hamburger, F.A. 1953: Drug therapy of heterophoria. Wiener Medizinische Wochenschrift 103(29-30): 533-534
Grosse-Brockhoff, F. 1957: Drug therapy of hypertension & its clinical results. Naunyn-Schmiedebergs Archiv für Experimentelle Pathologie und Pharmakologie 232(1): 198-218; Discussion 219-222
Wilkins, R.W. 1959: Drug therapy of hypertension in old age. Postgraduate Medicine 26(1): 59-63
Conner, P.K.; Dennis, E.; Kinard, S.A.; Moyer, J.H. 1956: Drug therapy of hypertension in the elderly patient. Geriatrics 11(12): 527-542
Moser, M.; Macaulay, A.I.; Granzen, R.; Trout, K.W. 1956: Drug therapy of hypertension. II. Experience with reserpine, apresoline, ansolysen, ecolid, and mecamylamine (inversine). New York State Journal of Medicine 56(16): 2487-2497
Moyer, J.H. 1956: Drug therapy of hypertension. IV. the indications and contraindications for antihypertensive drugs. A.M.A. Archives of Internal Medicine 98(4): 427-443
Christensen, L.K. 1963: Drug therapy of hypothyroidism. Nordisk Medicin 69: 89-92
Wohlmuth, G.; Kiss, P. 1960: Drug therapy of icterus gravis in premature infants. Gyermekgyogyaszat: Az Orvosegeszsegugyi Szakszervezet Gyermekorvos Szakcsoportjanak Folyoirata 11: 81-90
Kubovic, M.; Subotic, R. 1959: Drug therapy of malignant tumors. Radovi Medicinskog Faculteta U Zagrebu 7: 35-39
Marrazzi, A. 1958: Drug therapy of mental disease. A.M.A. Archives of Industrial Health 17(5): 398-402
Gottfries, C.G. 1963: Drug therapy of migraine. A communication occasioned by information in the daily press. Svenska Lakartidningen 60: 1555-1560
Weinberger, J.; Frishman, W.H.; Terashita, D. 2003: Drug therapy of neurovascular disease. Cardiology in Review 11(3): 122-146
Gobel, H. 1951: Drug therapy of nonspecific urinary tract inflammation based on recent developments (antibiotics, sulfonamides, urinary antiseptics). Die Medizinische Welt 20(39): 1216-1219
Aronow, W.S. 2006: Drug therapy of older persons with hypertension. Journal of the American Medical Directors Association 7(3): 193-196
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer. Ugeskrift for Laeger 167(45): 4261-4265
Willi, H. 1959: Drug therapy of premature infants and its dangers. Acta Pediatrica Espanola 17(196): 187-202
Nagaya, N. 2004: Drug therapy of primary pulmonary hypertension. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 4(2): 75-85
Wittern, U.; Hirschmüller, A.; Binswanger, L. 2002: Drug therapy of psychiatric patients in the middle of the 19th century: the drug armamentarium of Ludwig Binswanger sen. in his "Asyl Bellevue". Gesnerus 59(3-4): 198-223
Stawowy, K. 1961: Drug therapy of rheumatic disorders in ambulant practice. Medizinische Klinik 56: 2131-2133
Arndt, U.; Rittmeister, M.; Möller, B. 2003: Drug therapy of rheumatoid arthritis. Der Orthopade 32(12): 1095-1103
Ukhal', M.I.; Strashnyĭ, V.V.; Malomuzh, O.I.; Shumilin, M.V. 2002: Drug therapy of spastic disorder of urine outflow in patients with spinal injury and spinal cord injury. Likars'ka Sprava 8: 54-55
Limbourg, P. 2003: Drug therapy of stroke in the stroke unit. a race against time. MMW Fortschritte der Medizin 145(7): 43-44
Dalfino, G. 1958: Drug therapy of syndromes of pituitary hyperhormonism. La Clinica Terapeutica 15(1): 17-45
Beckett, P.G.; Gottlieb, J.S.; Lowinger, P.; Tourney, G. 1956: Drug therapy of the psychoses. Medical Clinics of North America 40(5): 1385-1399
Lichstein, J.; Dacosta Mayer, J. 1959: Drug therapy of the unstable bowel (irritable colon) a 15-month double blind clinical study in 75 cases of response to a prolonged-acting belladonna alkaloid-phenobarbital mixture or placebo. Journal of Chronic Diseases 9(4): 394-404
Krieger, K.; Kropp, E. 1961: Drug therapy of the varicose symptom complex. Die Medizinische Welt 24: 1319-1322
Pimentel, O.D.M. 1952: Drug therapy of thyrotoxicosis. Imprensa Medica 28(457): 65-72
Elverland, H.H. 2005: Drug therapy of tinnitus. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 125(23): 3275-3276
Canavero, S.; Bonicalzi, V. 2006: Drug therapy of trigeminal neuralgia. Expert Review of Neurotherapeutics 6(3): 429-440
Voorhorst, R. 1962: Drug therapy of vasomotor rhinitis and asthma: dibenzheptropine, a valuable adjuvant in the corticoid treatment. Current Therapeutic Research 4: 31-36
Peterlini, M.A.él.S.; Chaud, M.N.; Pedreira, M.d.L.G. 2003: Drug therapy orphans: the administration of intravenous drugs in hospitalized children. Revista Latino-Americana de Enfermagem 11(1): 88-95
Shaya, F.T.; El Khoury, A.C.; Mullins, C.D.; Du, D.; Skolasky, R.; Fatodu, H.; Garber, H.; Weir, M.R. 2006: Drug therapy persistence and stroke recurrence. American Journal of Managed Care 12(6): 313-319
Slim, K.; Le Borgne, J. 2003: Drug therapy prevention of pancreatic fistula after pancreaticoduodenectomy. Annales de Chirurgie 128(3): 175-176
Moriarty, J.D. 1960: Drug therapy versus psychotherapy. Journal of Neuropsychiatry 2: 82-85
Linn, E.L. 1959: Drug therapy, milieu change, and release from a mental hospital. A.M.A. Archives of Neurology and Psychiatry 81(6): 785-794
Pieper, S. 1963: Drug therapy. Meningeal leukemia. Medical Record and Annals 56: 32-33
Bieter, R.N. 1960: Drug therapy:1870. Journal-Lancet 80: 198-200
Funderburk, W.H.; Wilcox, K.W.; Wilcox, P.H. 1956: Drug therapy; physiodynamic therapy. Ii. Progress in Neurology and Psychiatry 11: 425-456
Di Mattei, P. 1960: Drug thesaurismoses. Actualites Pharmacologiques 13: 189-236
Waldbott, G.L.; Blair, K.E.; Mckeever, R. 1953: Drug tolerance in asthma; fatal salicylate poisoning from a physiologic dose. Annals of Allergy 11(2): 199-203
Winkelman, M. 2005: Drug tourism or spiritual healing? Ayahuasca seekers in Amazonia. Journal of Psychoactive Drugs 37(2): 209-218
Janzen, R. 1962: Drug toxicity and the nervous system. Der Internist 3: 471-477
Marini, L. 2002: Drug trafficking and international law. Annali Dell'istituto Superiore di Sanita 38(3): 323-330
Datta, S.; Banerjee, A.; Chandra, P.K.; Mahapatra, P.K.; Chakrabarti, S.; Chakravarty, R. 2006: Drug trafficking routes and hepatitis B in injection drug users, Manipur, India. Emerging Infectious Diseases 12(12): 1954-1957
Hung, O. 2006: Drug transformation: Advances in drug delivery systems. Canadian Journal of Anaesthesia 53(11): 1074-1077
Mannermaa, E.; Vellonen, K.-S.; Urtti, A. 2006: Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Advanced Drug Delivery Reviews 58(11): 1136-1163
Costa-Balogh, F.át.O.; Aberg, C.; Sousa, J.ão.J.S.; Sparr, E. 2005: Drug transport in responding lipid membranes can be regulated by an external osmotic gradient. Langmuir 21(23): 10307-10310
Ecker, G. 1999: Drug transport pumps: from molecular biology and pharmacology to clinical implications. Idrugs: the Investigational Drugs Journal 2(12): 1256-1257
Dai, H.; Elmquist, W.F. 2003: Drug transport studies using quantitative microdialysis. Methods in Molecular Medicine 89: 249-264
Schnyder, A.; Huwyler, J.ör. 2005: Drug transport to brain with targeted liposomes. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 2(1): 99-107
Olivier, J-Christophe. 2005: Drug transport to brain with targeted nanoparticles. Neurorx: the Journal of the American Society for Experimental Neurotherapeutics 2(1): 108-119
Ritchie, M.D.; Haas, D.W.; Motsinger, A.A.; Donahue, J.P.; Erdem, H.; Raffanti, S.; Rebeiro, P.; George, A.L.; Kim, R.B.; Haines, J.L.; Sterling, T.R. 2006: Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 43(6): 779-782
Mizuno, N.; Niwa, T. 2005: Drug transporter studies in drug discovery and development. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 125(4): 200-206
Kim, R.B. 2003: Drug transporters in HIV Therapy. Topics in HIV Medicine: a Publication of the International Aids Society Usa 11(4): 136-139
Thomas, S.A. 2004: Drug transporters relevant to HIV therapy. Journal of HIV Therapy 9(4): 92-96
Mizuno, N.; Sugiyama, Y. 2002: Drug transporters: their role and importance in the selection and development of new drugs. Drug Metabolism and Pharmacokinetics 17(2): 93-108
Spöhr, F.; Wenzel, V.; Böttiger, B.W. 2006: Drug treatment and thrombolytics during cardiopulmonary resuscitation. Current Opinion in Anaesthesiology 19(2): 157-165
Kerr, T. 2002: Drug treatment court opens in British Columbia. Canadian Hiv/Aids Policy and Law Review 6(3): 36-37
Christie, T.; Anderson, J.F. 2003: Drug treatment courts are popular but do they work and are they ethical and appropriate for Canada?. Health Law in Canada 23(4): 70-79
Puhó, E.éb.H.; Szunyogh, M.; Métneki, J.úl.; Czeizel, A.E. 2007: Drug treatment during pregnancy and isolated orofacial clefts in hungary. Cleft Palate-Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association 44(2): 194-202
Zheng, W.; Su, J.; Cai, L.; Lou, Y.; Wang, J.; Guo, X.; Tang, J.; Chen, H. 2018: Application of 3D-printing technology in the treatment of humeral intercondylar fractures. Orthopaedics and Traumatology Surgery and Research: Otsr 104(1): 83-88
Maidment, I.; Fox, C.; Livingston, G.; Katona, C. 2006: Drug treatment for Alzheimer's disease: the way forward. International Journal of Geriatric Psychiatry 21(1): 6-8
Roehrborn, C.G. 2006: Drug treatment for LUTS and BPH: new is not always better. European Urology 49(1): 5-7
Anonymous 2005: Drug treatment for alcoholism today. Harvard Mental Health Letter 22(1): 3-5
Ben-Pazi, H. 2006: Drug treatment for children with cerebral palsy. Harefuah 145(7): 510
Wark, P. 2003: Drug treatment for chronic obstructive pulmonary disease. Idrugs: the Investigational Drugs Journal 6(9): 874-879
Rose, M.R.; Tawil, R. 2004: Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database of Systematic Reviews 2: Cd002276
Bird, H.A. 2004: Drug treatment for fibromyalgia. Musculoskeletal Care 2(2): 90-100
Sakakibara, R.; Uchiyama, T.; Hattori, T. 2006: Drug treatment for geriatric urinary disorders; current concept. Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 43(4): 415-422
Hillilä, M.; Färkkilä, M. 2004: Drug treatment for irritable bowel syndrome. Duodecim; Laaketieteellinen Aikakauskirja 120(20): 2453-2458
Trip, J.; Drost, G.; van Engelen, B.G.M.; Faber, C.G. 2006: Drug treatment for myotonia. Cochrane Database of Systematic Reviews 1: Cd004762
Mela, M.; Mancuso, A.; Burroughs, A. 2002: Drug treatment for portal hypertension. Annals of Hepatology 1(3): 102-120
Vattakatuchery, J.J. 2006: Drug treatment for psychotic depression. British journal of psychiatry: the journal of mental science 189: 383; author reply 383
Tielmans, A.él.; Virally, M.; Coupaye, M.; Laloi-Michelin, M.; Méas, T.; Guillausseau, P.-J. 2007: Drug treatment in type 2 diabetes (part 2). Presse Medicale 36(3 Part 2): 467-474
Barbui, C.; Ciuna, A.; Nosè, M.; Levi, D.; Andretta, M.; Patten, S.B.; Amaddeo, F.; Tansella, M. 2005: Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison. European Archives of Psychiatry and Clinical Neuroscience 255(2): 136-142
Lyon, R.L. 1962: Drug treatment of Huntington's chorea. a trial with thiopropazate. British Medical Journal 1(5288): 1308-1310
Massironi, G.; Galluzzi, S.; Frisoni, G.B. 2003: Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies. International Psychogeriatrics 15(4): 377-383
Letman, H. 1963: Drug treatment of acquired hemolytic anemia. Nordisk Medicin 70: 779-780
Solms, H. 1952: Drug treatment of alcoholism with special consideration to antabuse. Ii. Münchener Medizinische Wochenschrift 94(13): 610
Solms, H. 1952: Drug treatment of alcoholism with special reference to antabuse I... Münchener Medizinische Wochenschrift 94(12): 560-563
Janko, S.; Hoffmann, E. 2006: Drug treatment of atrial fibrillation. MMW Fortschritte der Medizin 148(15): 32-35
Miller, M.C. 2006: Caregiver stress: when helpers need help. Harvard Mental Health Letter 22(11): 8
Scadding, J.G. 1959: Drug treatment of chronic bronchitis. British Medical Journal 1(5114): 107-109
Böhm, M.; Werner, N.; Kindermann, M. 2006: Drug treatment of chronic heart failure. Clinical Research in Cardiology: Official Journal of the German Cardiac Society 95(Suppl 4): 36-54; Quiz: 55-56
Groot, M.T.; Ossenkoppele, G.J.; Kramer, M.H.; van den Boom, G.; Huijgens, P.C.; Uyl-de Groot, C.A. 2003: Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment. Nederlands Tijdschrift Voor Geneeskunde 147(30): 1460-1465
De Miguel Díez, J.; Izquierdo Alonso, J.L.; Rodríguez González-Moro, J.M.; de Lucas Ramos, P.; Molina París, J. 2003: Drug treatment of chronic obstructive pulmonary disease on two levels of patient care: degree of compliance with recommended protocols. Archivos de Bronconeumologia 39(5): 195-202
Wierzbicki, A.S.; Mikhailidis, D.P.; Wray, R. 2001: Drug treatment of combined hyperlipidemia. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 1(5): 327-336
Ezechukwu, C.C.; Egbuonu, I.; Chukwuka, J.O. 2005: Drug treatment of common childhood symptoms in Nnewi: what mothers do?. Nigerian Journal of Clinical Practice 8(1): 1-3
Schulsinger, F. 1961: Drug treatment of confused senile patients. Nordisk Medicin 66: 1545-1548
Pieper, A.A.; Treisman, G.J. 2005: Drug treatment of depression in HIV-positive patients : safety considerations. Drug Safety 28(9): 753-762
Baghai, T.C.; Volz, H-Peter.; Möller, H-Jürgen. 2006: Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities. World Journal of Biological Psychiatry: the Official Journal of the World Federation of Societies of Biological Psychiatry 7(4): 198-222
Kielholz, P. 1959: Drug treatment of depressive states. Canadian Psychiatric Association Journal 4(Suppl): 129-137
Pfeiffer, E.F. 1961: Drug treatment of diabetes mellitus. Therapie der Gegenwart 100: 198-208
Anning, S.T. 1959: Drug treatment of eczema. British Medical Journal 2(5159): 1087-1089
Holt, K.S. 1956: Drug treatment of enuresis; controlled trials with propantheline, amphetamine, and pituitary snuff. Lancet 271(6957): 1334-1336
Hildebrand, J.; Van Bogaert, P.; Tugendhaft, P.; Thiriaux, A. 2002: Drug treatment of epilepsy: update. Revue Medicale de Bruxelles 23(6): 500-503
Kwan, P.; Brodie, M.J. 2004: Drug treatment of epilepsy: when does it fail and how to optimize its use?. Cns Spectrums 9(2): 110-119
Welsh, L.; Ferro, A. 2004: Drug treatment of essential hypertension: the case for initial combination therapy. International Journal of Clinical Practice 58(10): 956-963
James, D.M.; Morris, T.G.; Marks, J. 1960: Drug treatment of experimental silicosis. British Journal of Industrial Medicine 17: 36-40
Weusten, B.L.; Exalto, N.; Otten, M.H. 2003: Drug treatment of gastro-esophageal reflux disease in pregnant women: consensus guidelines of gastroenterologists and gynaecologists. Nederlands Tijdschrift Voor Geneeskunde 147(50): 2471-2474
Misra, M.C.; Imlitemsu 2005: Drug treatment of haemorrhoids. Drugs 65(11): 1481-1491
Liu, G.; Wang, W.; Wan, Y.; Ju, X.; Gu, S. 2018: Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors. International Journal of Molecular Sciences 19(5)
Ashcroft, J.S. 2003: Drug treatment of hypertension. Thiazides with your pension?. Bmj 326(7392): 764
Fenves, A.Z.; Ram, C.V.S. 2005: Drug treatment of hypertensive urgencies and emergencies. Seminars in Nephrology 25(4): 272-280
Quadbeck, B.; Hörmann, R.; Janssen, O.E.; Mann, K. 2003: Drug treatment of immune hyperthyroidism (Basedow disease). Patient selection, long-term follow-up and prevention of recurrence. Der Internist 44(4): 440-448
Gaisford, W. 1959: Drug treatment of infants and children suffering from pneumonia. British Medical Journal 1(5116): 230-232
Achari, G.; Das, M.; Sinha, C.N. 1960: Drug treatment of infective hepatitis. Journal of the Indian Medical Association 34: 488-490
Siegel, D.M. 1998: Drug treatment of juvenile arthritis: accepted therapeutic options. Drugs of Today 34(4): 327-340
Adams, A.R. 1959: Drug treatment of malaria. British Medical Journal 2(5145): 183-184
Heathfield, K.W. 1961: Drug treatment of migraine. Current Medicine and Drugs 1: 25-30
Carmo, K.B.; Barr, P. 2005: Drug treatment of neonatal seizures by neonatologists and paediatric neurologists. Journal of Paediatrics and Child Health 41(7): 313-316
Turner, J.W.A. 1958: Drug treatment of neuritis. British Medical Journal 2(5109): 1403-1404
Fisher, H. 1960: Drug treatment of neurosis: blessing or curse?. Arzneimittel-Forschung 10: 347-349
Kalikstad, B.; Hansen, T.W.R. 2003: Drug treatment of newborn infants--a chance taking?. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(19): 2738-2740
Lamarre-Cliche, M. 2002: Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 2(1): 23-35
Critchley, M. 1958: Drug treatment of parkinsonism. British Medical Journal 2(5106): 1214-1215
Mills, R.M.; Hobbs, R.E. 2001: Drug treatment of patients with decompensated heart failure. American Journal of Cardiovascular Drugs: Drugs Devices and other Interventions 1(2): 119-125
Aronow, W.S. 2006: Drug treatment of peripheral arterial disease in the elderly. Drugs and Aging 23(1): 1-12
Neralla, S.; Meyer, K.C. 2004: Drug treatment of pneumococcal pneumonia in the elderly. Drugs and Aging 21(13): 851-864
Nicholson, H. 1959: Drug treatment of pneumonia in adults. British Medical Journal 1(5115): 162-165
Roux, C.; Briot, K.; Dumarcet, N.; Bourgoin, M.; Chapurlat, R.; Christin-Maitre, S.; Cortet, B.; Costagliola, D.; Diebolt, V.; Lacoin, Fçois.; Letombe, B.; Oberlin, F.; Orcel, P.; Ravaud, P.; Seret, P.; Thomas, T.; Vogel, J-Yves.; Barna, A.; Nouyrigat, E.; Veyries, M-Laure.; Yoldjian, I. 2006: Drug treatment of postmenopausal osteoporosis. What's New in 2006. Presse Medicale 35(10 Pt 2): 1529-1539
Bakheit, A.M.O. 2004: Drug treatment of poststroke aphasia. Expert Review of Neurotherapeutics 4(2): 211-217
Hoeper, M.M. 2005: Drug treatment of pulmonary arterial hypertension: current and future agents. Drugs 65(10): 1337-1354
Batalla Sabate, L. 1962: Drug treatment of renoureteral lithiasis. Medicina Clinica 39: 164-168
Anonymous 2004: Drug treatment of schizophrenia: what experts are recommending. Harvard Mental Health Letter 21(4): 4-7
Wiegand, M.H. 2003: Drug treatment of sleep disorders in the elderly. Der Internist 44(9): 1187-1192
Aronow, W.S. 2005: Drug treatment of systolic and of diastolic heart failure in elderly persons. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 60(12): 1597-1605
Chole, R.; Patil, R.; Degwekar, S.S.; Bhowate, R.R. 2007: Drug treatment of trigeminal neuralgia: a systematic review of the literature. Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 65(1): 40-45
Crofton, J. 1960: Drug treatment of tuberculosis. I. Standard chemotherapy. British Medical Journal 2(5195): 370-373
Crofton, J. 1960: Drug treatment of tuberculosis. II. Treatment of patients with tubercle bacilli resistant to standard chemotherapy. British Medical Journal 2(5196): 449-451
Tielmans, A.él.; Laloi-Michelin, M.; Coupaye, M.; Virally, M.; Meas, T.; Guillausseau, P.-J. 2007: Drug treatment of type 2 diabetes. Presse Medicale 36(2 Part 2): 269-278
Lowey, A. 2005: Drug treatment of type 2 diabetes in adults. Nursing Standard: 20(11): 55-64; Quiz 66
Malhotra, S.; Bhasin, D.; Shafiq, N.; Pandhi, P. 2004: Drug treatment of ulcerative colitis: unfractionated heparin, low molecular weight heparins and beyond. Expert Opinion on PharmacoTherapy 5(2): 329-334
Hattori, T. 1998: Drug treatment of urinary incontinence. Drugs of Today 34(2): 125-138
Flippin, H.F. 1958: Drug treatment of urinary tract infections or, Gelmo revisited. Journal of the Medical Association of Georgia 47(8): 375-383
Strauss, S.M.; Astone-Twerell, J.; Munoz-Plaza, C.E.; Des Jarlais, D.C.; Gwadz, M.; Hagan, H.; Osborne, A.; Rosenblum, A. 2007: Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services. Bmc Health Services Research 7: 39
Niv, N.; Hser, Y.-I. 2006: Drug treatment service utilization and outcomes for Hispanic and white methamphetamine abusers. Health Services Research 41(4 Part 1): 1242-1257
Hansen, H.; Alegría, M.; Cabán, C.A.; Peña, M.; Lai, S.; Shrout, P. 2004: Drug treatment, health, and social service utilization by substance abusing women from a community-based sample. Medical Care 42(11): 1117-1124
Vosloo, A.H. 1951: Drug treatment--a survey. South African Medical Journal 25(20): 342-349
Alrajhi, A.A. 2003: Cutaneous leishmaniasis of the Old World. Skin Therapy Letter 8(2): 1-4
Dang, C.T. 2006: Drug treatments for adjuvant chemotherapy in breast cancer: recent trials and future directions. Expert Review of Anticancer Therapy 6(3): 427-436
Anonymous 2005: Drug treatments for bipolar disorder: 1--Acute manic or depressive episodes. Drug and Therapeutics Bulletin 43(4): 28-32
Henson, R. 2005: What can functional neuroimaging tell the experimental psychologist?. Quarterly Journal of Experimental Psychology. a Human Experimental Psychology 58(2): 193-233
Crestani, B.; Marchand-Adam, S.; Schneider, S. 2005: Drug treatments for idiopathic pulmonary fibrosis. Revue de Pneumologie Clinique 61(3): 221-231
Kripke, C. 2004: Drug treatments for patients with dysthymia. American Family Physician 70(7): 1269-1270
Almeida, M.J.é d.; Yoshida, W.B.; Melo, N.R.d. 2004: Popliteal artery entrapment syndrome. Revista Portuguesa de Cirurgia Cardio-Toracica e Vascular: Orgao Oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular 10(4): 199-206
Smith, P.F.; Darlington, C.L. 2005: Drug treatments for subjective tinnitus: serendipitous discovery versus rational drug design. Current Opinion in Investigational Drugs 6(7): 712-716
Amedee, R.G.; Risey, J. 2000: Drug treatments for tinnitus: the Tulane experience. International Tinnitus Journal 6(1): 63-66
Fernandez, H.; Azoulay, C.; Rostoker, G. 2005: Drug treatments for uterine fibroma: rationale. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 34(4): 360-405
Anonymous 2005: Drug treats two sources of cholesterol. Nurse Practitioner 30(3): 70
Anonymous 2005: Drug trend data provide benchmarks for Blue Cross Blue Shield Plans. Capitation Rates and Data 10(7): 82-84
Mihăescu, G.; Manolescu, B.; Petrache, L.M.; Balotescu, C.; Israil, A.M. 2004: Effect of transferrin on the expression of virulence factors in Listeria monocytogenes strains. Bacteriologia Virusologia Parazitologia Epidemiologia 48(2-3): 149-152
Somberg, J. 2004: Drug trial registries. American Journal of Therapeutics 11(5): 327
Otte, A. 2007: Drug trials in humans. Risks in the light of the London catastrophe. Der Internist 48(6): 636-641
Marshall, E. 2006: Drug trials. Violent reaction to monoclonal antibody therapy remains a mystery. Science 311(5768): 1688-1689
Jha, T.K. 2006: Drug unresponsiveness and combination therapy for kala-azar. Indian Journal of Medical Research 123(3): 389-398
Nevin, J. 2004: Drug update: Fentanyl patch abuse. Emergency Medical Services 33(7): 24-25
Bauer, A.W.; Perry, D.M.; Kirby, W.M. 1960: Drug usage and antibiotic susceptibility of staphylococci. Journal of the American Medical Association 173: 475-480
Boon, A.E.; de Boer, S.B.B. 2007: Drug usage as a treat to the stability of treatment outcome: a one-year follow-up study of adolescent psychiatric patients. European Child and Adolescent Psychiatry 16(2): 79-86
Knopf, H. 2004: Drug usage of men and women with coronary heart disease. Results of the German Federal Health Survey 1998. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47(11): 1051-1055
Anonymous 1995: Drug use. Drug and Alcohol Review 14(4): 421-431
Wodak, A. 1996: Drug use. Drug and Alcohol Review 15(2): 209-212
Wodak, A. 1996: Drug use. Drug and Alcohol Review 15(4): 433-438
Lerman, Y.; Israelshvilli, M.; Vardi, D.; Slepon, R. 1993: Drug use among Israeli army personnel: an epidemiological study. Drug and Alcohol Review 12(1): 59-69
Lawoyin, T.O.; Ajumobi, O.O.; Abdul, M.M.; Abdul Malik, J.O.; Adegoke, D.A.; Agbedeyi, O.A. 2005: Drug use among senior secondary school students in rural Nigeria. African Journal of Medicine and Medical Sciences 34(4): 355-359
Huo, D.; Bailey, S.L.; Hershow, R.C.; Ouellet, L. 2005: Drug use and HIV risk practices of secondary and primary needle exchange users. Aids Education and Prevention: Official Publication of the International Society for Aids Education 17(2): 170-184
Liu, Z.; Lian, Z.; Zhao, C. 2006: Drug use and HIV/AIDS in China. Drug and Alcohol Review 25(2): 173-175
Iqbal, N. 2003: Drug use and acute abdomen. Annals of Saudi Medicine 23(1-2): 91-93
Ilett, K.F.; Kristensen, J.H. 2005: Drug use and breastfeeding. Expert Opinion on Drug Safety 4(4): 745-768
Todd, C.S.; Safi, N.; Strathdee, S.A. 2005: Drug use and harm reduction in Afghanistan. Harm Reduction Journal 2: 13
Stauffer, L. 2004: Drug use and harm reduction policy: alternative perspectives on the California proposal. Journal of Health and Social Policy 19(3): 19-36
Hoa, N.Q.; Ohman, A.; Lundborg, C.S.ål.; Chuc, N.T.K. 2007: Drug use and health-seeking behavior for childhood illness in Vietnam--a qualitative study. Health Policy 82(3): 320-329
Hinkin, C.H.; Barclay, T.R.; Castellon, S.A.; Levine, A.J.; Durvasula, R.S.; Marion, S.D.; Myers, H.F.; Longshore, D. 2007: Drug use and medication adherence among HIV-1 infected individuals. Aids and Behavior 11(2): 185-194
Ulfvarson, J.; Adami, J.; Bardage, C.; von Bahr, C.; Wredling, R. 2005: Drug use and perceived health in recently hospitalized older people. British Journal of Community Nursing 10(10): 469-474
Degenhardt, L. 2005: Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference?. Culture Health and Sexuality 7(6): 599-614
Roxburgh, A.; Degenhardt, L.; Breen, C. 2005: Drug use and risk behaviours among injecting drug users: a comparison between sex workers and non-sex workers in Sydney, Australia. Harm Reduction Journal 2(1): 7
Maxwell, J.C.; Cravioto, P.; Galván, F.; Ramírez, M.C.és.; Wallisch, L.S.; Spence, R.T. 2006: Drug use and risk of HIV/AIDS on the Mexico-USA border: a comparison of treatment admissions in both countries. Drug and Alcohol Dependence 82(Suppl 1): S85-S93
Martin, R.E.; Gold, F.; Murphy, W.; Remple, V.; Berkowitz, J.; Money, D. 2005: Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia. Canadian Journal of Public Health 96(2): 97-101
Anders, J.; V Renteln-Kruse, W.; Dapp, U.; Gillmann, G.; Stuck, A. 2005: Drug use and self-perceived health as reported by community-dwelling elderly persons in Hamburg. Zeitschrift für Gerontologie und Geriatrie 38(3): 173-181
Gokhale, R. 2006: Drug use and sexually transmitted infections. International Journal of Std and Aids 17(10): 711-712
Coumans, M.; Spreen, M. 2003: Drug use and the role of homelessness in the process of marginalization. Substance use and Misuse 38(3-6): 311-338
Irl, C.; Kipferler, P.; Hasford, J. 1997: Drug use assessment and risk evaluation in pregnancy--the PEGASUS-project. Pharmacoepidemiology and Drug Safety 6(Suppl 3): S37-S42
Johnson, H. 2006: Drug use by incarcerated women offenders. Drug and Alcohol Review 25(5): 433-437
Cottler, L.B. 2007: Drug use disorders in the National Comorbidity Survey: have we come a long way?. Archives of General Psychiatry 64(3): 380
Bianca, S. 2003: Drug use during pregnancy: are risk classifications more dangerous than the drugs?. Lancet 362(9380): 329
López Briz, E. 2005: Drug use evaluation and social pharmacology. Medicina Clinica 125(13): 517; Author Reply 517-8
Boucher, M.; Vaillancourt, R.ég.; McCarthy, A. 2003: Drug use evaluation of oral antibiotics prescribed in the ambulatory care settings in the Canadian armed forces. Canadian Journal of Clinical Pharmacology 10(1): 5-10
Arinzon, Z.; Peisakh, A.; Zuta, A.; Berner, Y.N. 2006: Drug use in a geriatric long-term care setting: comparison between newly admitted and institutionalised patients. Drugs and Aging 23(2): 157-165
López Martínez, R.; Cabañas Poy, M.J.; Oliveras Arenas, M.; Clemente Bautista, S. 2005: Drug use in a neonatal ICU: a prospective study. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 29(1): 26-29
Feal Cortizas, B.; Barroso Pérez, C.; Carcelen Andrés, J.; Fábrega Bosacoma, C.; Gallego Lago, V.; Hidalgo Albert, E.; Pozas Del Río, M.T.; Puy Goyache, M.; Revert Molina-Niñirola, A.; Valverde Molina, E.; Wood Wood, M.A. 2003: Drug use in neonatology units of 6 Spanish hospitals. Farmacia Hospitalaria: Organo Oficial de Expresion Cientifica de la Sociedad Espanola de Farmacia Hospitalaria 27(2): 69-71
Von Mandach, U. 2005: Drug use in pregnancy. Therapeutische Umschau. Revue Therapeutique 62(1): 29-35
Ambrose, P.J. 2004: Drug use in sports: a veritable arena for pharmacists. Journal of the American Pharmacists Association: Japha 44(4): 501
Smith, F. 2003: Drug use in sub-Saharan Africa: quality in processes--safety in use. Quality and Safety in Health Care 12(3): 164-165
Ball, D.E.; Maidza, J.; Rusike, T.; Sharief, K.; Taderera, T.; Tangawarima, T. 2000: Drug use indicators at St Mary's Clinic. Central African Journal of Medicine 46(2): 54-55
Kraus, L.; Augustin, R.; Kunz-Ebrecht, S.; Orth, B. 2007: Drug use patterns and drug-related disorders of cocaine users in a sample of the general population in Germany. European Addiction Research 13(2): 116-125
Fleming, J.; Watson, C.; McDonald, D.; Alexander, K. 1991: Drug use patterns in Northern Territory Aboriginal communities 1986-1987. Drug and Alcohol Review 10(4): 367-380
Corliss, H.L.; Grella, C.E.; Mays, V.M.; Cochran, S.D. 2006: Drug use, drug severity, and help-seeking behaviors of lesbian and bisexual women. Journal of Women's Health 15(5): 556-568
Beyrer, C.; Jittiwutikarn, J.; Teokul, W.; Razak, M.H.; Suriyanon, V.; Srirak, N.; Vongchuk, T.; Tovanabutra, S.; Sripaipan, T.; Celentano, D.D. 2003: Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. Aids and Behavior 7(2): 153-161
Galea, S.; Rudenstine, S.; Vlahov, D. 2005: Drug use, misuse, and the urban environment. Drug and Alcohol Review 24(2): 127-136
Durisova, A.; Magulova, L. 2004: Drug use--problem in pregnancy. Bratislavske Lekarske Listy 105(3): 123-124
Whittier, J.R.; Korenyi, C.D.; Diamond, O.; Tomlinson, P.J.; Laburt, H.A. 1959: Drug use-rate in a state hospital. American Journal of Psychiatry 116: 169-171
Monahan, G. 2003: Drug use/misuse among health professionals. Substance use and Misuse 38(11-13): 1877-1881
Anonymous 2004: Drug user groups and their impact on policy. Addiction 99(4): 526
Brown, H. 2006: Drug users carry the main burden of Russia's epidemic of HIV. Lancet. Infectious Diseases 6(7): 394
Anonymous 2004: Drug users embrace Vancouver site. Aids Patient Care and Stds 18(3): 186
Mayor, S. 2003: Drug users in China tested for HIV without consent. Bmj 327(7415): 579
van der Poel, A.; Barendregt, C.; van de Mheen, D. 2006: Drug users' participation in addiction care: different groups do different things. Journal of Psychoactive Drugs 38(2): 123-132
Wettermark, B.ör.; Pehrsson, A.; Jinnerot, D.; Bergman, U. 2003: Drug utilisation 90% profiles--a useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiology and Drug Safety 12(6): 499-510
Schlander, M. 2005: Drug utilization and pharmaceutical cost-containment in germany-perspectives 1 year after enactment of the GMG. Medizinische Klinik 100(6): 314-324
Bengt, J.ön.; Arvidsson, G.ör.; Levin, L.-A.; Rehnberg, C. 2005: Drug utilization decisions should be based on cost-benefit data. Lakartidningen 102(16): 1264-1265; Discussion 1265
Bertoldi, A.éa.D.; Barros, A.ís.J.D.; Hallal, P.C.; Lima, R.ân.C. 2004: Drug utilization in adults: prevalence and individuals determinants. Revista de Saude Publica 38(2): 228-238
Doucet, J.; Otero, G.èv. 2003: Drug utilization in the elderly. SOINS. Gerontologie 40: 16-18
Bestehorn, K.; Völler, H.; Benecke, H.; Renner, H.; Karmann, B.; Wegscheider, K. 2006: Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment. Current Medical Research and Opinion 22(4): 631-639
Letourneau, K.N.; Letourneau, K.N. 2006: Drug utilization review in an extended care facility. 1974. Annals of PharmacoTherapy 40(5): 956-962
Llanes, L.R.; Fassbender, K.; Baracos, V.E.; Watanabe, S. 2006: Drug utilization review on a tertiary palliative care unit. Journal of Pain and Symptom Management 31(5): 457-464
Estiarte, R.ón.; Juan, J.; Colomé, E.; Artés, M.; Jiménez, F.J. 2003: Drug utilization study in patients with Crohn's disease in Spain. European Journal of Gastroenterology and Hepatology 15(4): 355-362
Brodie, D.C. 2006: Drug utilization--a public health problem. Annals of PharmacoTherapy 40(11): 2029
Eber, B.L. 2005: Drug utilization: using objective data to achieve cost-efficiency. Benefits Quarterly 21(1): 7-13
Malik, P. 2005: Drug warranties and shared responsibility. Canadian Journal of Cardiology 21(5): 403
Rosenberg, D. 2004: Drug wars ahead. Newsweek 144(23): 72 74
Bryan, C.S. 2003: Drug wars: saying no. Journal of the South Carolina Medical Association 99(6): 173-174
Keller, D. 2006: Drug watch '06. Pain relievers. Rn 69(4): 22-27; Quiz 28
Dest, V. 2006: Drug watch 2006: cancer therapies. Rn 69(6): 31-36; Quiz 37
Wooten, J.M. 2006: Drug watch 2006: new frontiers. Rn 69(3): 36-40; Quiz 41
Hawes, J. 2005: Drug watch. Pipeline progress: then and now. Beta: Bulletin of Experimental Treatments for Aids: a Publication of the San Francisco Aids Foundation 17(4): 15-17
Rolo, A. 1962: Drug withdrawal with promazine hydrochloride. New York State Journal of Medicine 62: 1429-1431
Foy, A. 1991: Drug withdrawal: a selective review. Drug and Alcohol Review 10(3): 203-214
Smith, D.A.; Schmid, E.F. 2006: Drug withdrawals and the lessons within. Current Opinion in Drug Discovery and Development 9(1): 38-46
Lexchin, J. 2005: Drug withdrawals from the Canadian market for safety reasons, 1963-2004. Cmaj: Canadian Medical Association Journal 172(6): 765-767
Millán, C.G.ér.; Marinero, M.ía.L.S.; Castañeda, A.án.Z.; Lanao, J.é M. 2004: Drug, enzyme and peptide delivery using erythrocytes as carriers. Journal of Controlled Release: Official Journal of the Controlled Release Society 95(1): 27-49
Galetto, A.; Buttiglieri, S.; Forno, S.; Moro, F.; Mussa, A.; Matera, L. 2003: Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells. Anti-Cancer Drugs 14(10): 833-843
Mohi-ud-din, R.; Lewis, J.H. 2004: Drug- and chemical-induced cholestasis. Clinics in Liver Disease 8(1): 95
Wills, B.; Erickson, T. 2005: Drug- and toxin-associated seizures. Medical Clinics of North America 89(6): 1297-1321
Jiji, R.M. 1964: Drug--Induced Blood Dyscrasias. Medical Times 92: 161-162
Ríhová, B.; Strohalm, J.í; Kubácková, K.; Jelínková, M.ét.; Rozprimová, L.; Sírová, M.; Plocová, D.; Mrkvan, T.ás.; Kovár, M.; Pokorná, J.; Etrych, T.ás.; Ulbrich, K. 2003: Drug-HPMA-HuIg conjugates effective against human solid cancer. Advances in Experimental Medicine and Biology 519: 125-143
Prusak, Y.; Lurie, E. 1964: Drug-Induced Agranulocytosis. Harefuah 67: 16-21
Bennett, N.M. 1963: Drug-Induced Agranulocytosis and Septicaemia. Medical Journal of Australia 2: 575-577
Bernard, R. 1964: Drug-Induced Aplastic Panmyelopathy Due to Chloramphenicol Idiosyncrasy. Belgisch Tijdschrift Voor Geneeskunde 20: 230-233
Huguley, C.M. 1963: Drug-Induced Blood Dyscrasias. Disease-A-Month: Dm 24: 1963: 1-196352
Beutler, E. 1964: Drug-Induced Blood Dyscrasias. Iii. Hemolytic Anemia. JAMA 189: 143-144
Mclaughlin, L.A. 1963: Drug-Induced Diabetes. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 115: 355-357
Khaitov, A. 1963: Drug-Induced Disease with the Clinical Picture of Capillary Toxicosis (Schoenlein-Henoch Disease). Suvremenna Meditsina 14: 53-55
White, R.P.; Sewell, H.H.; Rudolph, A.S. 1965: Drug-Induced Dissociation between Evoked Reticular Potentials and the Eeg. Electroencephalography and Clinical Neurophysiology 19: 16-24
Billich, R.; Willmes, H. 1964: Drug-Induced Exanthema in the Cytostatic Treatment of Genital Carcinoma in Women. Geburtshilfe und Frauenheilkunde 24: 497-506
Krentz, K.; Baethke, R. 1963: Drug-Induced Gastrointestinal Ulcer and its Practical Significance. Die Medizinische Welt 36: 1777-1781
Okubo, A. 1964: Drug-Induced Hematopoietic Disorders. Nihon Ishikai Zasshi. Journal of the Japan Medical Association 51: 829-840
Palek, J. 1965: Drug-Induced Hemolytic Conditions. Casopis Lekaru Ceskych 104: 592-595
Bobek, K.; Horakova, Z.; Cepelak, V. 1965: Drug-Induced Hemorrhages in the Treatment with Pyrazolones and Anticoagulants. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 20(Suppl): 309-311
Berthelot, P.; Sicot, C.; Benhamou, J.P.; Fauvert, R. 1965: Drug-Induced Hepatitis. Ii. Analytic Study of Responsible Drugs. Revue Francaise d'Etudes Cliniques et Biologiques 10: 140-179
Yamamoto, S.; Igami, H. 1964: Drug-Induced Liver Damage and Countermeasures. Therapy 46: 897-904
Sedan, J. 1964: Drug-Induced Ocular Pathology. Annales d'Oculistique 197: 1138-1183
Lichtigfeld, F.J. 1964: Drug-Induced Parkinsonian Syndrome in a Case of Tranquillizer Poisoning. British Journal of Psychiatry: the Journal of Mental Science 110: 226-227
Gemperle, M. 1964: Drug-Induced Reduction of Oxygen Intake in Neuroleptanalgesia. Der Anaesthesist 13: 181-182
Whisson, M.E.; Connors, T.A. 1965: Drug-Induced Regression of Large Plasma Cell Tumours. Nature 205: 406
Kauppinen, K.; Rechardt, L. 1963: Drug-Induced Skin Eruptions Treated at the Helsinki University Dermatological Clinic 1956-1960. Duodecim; laaketieteellinen aikakauskirja 79: 269-272
Crosby, W.H.; Kaufman, R.M. 1964: Drug-Induced Thrombocytopenia. Medical Annals of the District of Columbia 33: 199-201
Vilarbonet, J. 1963: Drug-Induced Ulcer (Corticosteroids: Phenylbutazone). Medicina Clinica 41: 336-338
Amdisen, A. 1964: Drug-Produced Obesity. Experiences with Chlorpromazine, Perphenazine and Clopenthixol. Danish Medical Bulletin 11: 182-189
Wilmanns, W.; Hamfelt, A. 1964: Drug-Related Disorders of Blood cell Maturation by Inhibition of the Folic Acid Metabolism Enzyme. Verhandlungen der Deutschen Gesellschaft für Innere Medizin 70: 586-591
Pines, A.; Richardson, R.J. 1964: Drug-Resistance in Patients with Pulmonary Tuberculosis Presenting at Chest Clinics in Hong Kong. Tubercle 45: 77-95
Egawa, R.; Oshima, H.; Kawaharada, U.; Kono, M.; Mitsuhashi, S. 1964: Drug-Resistance of Staphylococci. 3. Impairment of Antimicrobial Activity of Streptomycin by Increase in Salt Concentration. Gunma Journal of Medical Sciences 13: 171-173
Mikata, I.; Tomioka, H. 1964: Drug-Resistance of Streptococcus Viridans and Streptococcus Hemolyticus. Journal of Antibiotics. Ser. B 17: 119-126
Hawking, F. 1963: Drug-Resistance of Trypanosoma Congolense and other Trypanosomes to Quinapyramine, Phenanthridines, Berenil and other Compounds in Mice. Annals of Tropical Medicine and Parasitology 57: 262-282
Ichihashi, Y. 1964: Drug-Resistance Patterns of Pneumococci and Epidemiologic and Genetic Problems. Journal of Antibiotics. Ser. B 17: 116-119
Yoshioka, M. 1964: Drug-Resistance Patterns of Streptococcus Hemolyticus and Epidemiologic and Genetic Problems. Journal of Antibiotics. Ser. B 17: 126-129
Martin, I. 1964: Drug-Resistant Tuberculosis in Great Britain. British Medical Journal 1(5379): 324-325
Gorham, D.R.; Overall, J.E. 1960: Drug-action profiles based on an abbreviated psychiatric rating scale. Journal of Nervous and Mental Disease 131: 528-535
Atreja, A.; Buck, M.; Jain, A.; Brunker, C.; Suh, T.T.; Harris, C.Martin.; Palmer, R.; Wilcox, A. 2005: Drug-age alerting for outpatient geriatric prescriptions: a joint study using interoperable drug standards. AMIA .. Annual Symposium Proceedings. AMIA Symposium 2005: 886
Cole, C.D.; Wang, H.E.; Abo, B.N.; Yealy, D.M. 2006: Drug-assisted effects on protective airway reflexes during out-of-hospital endotracheal intubation (preliminary report). Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 10(4): 472-475
Anonymous 2005: Drug-assisted intubation in the prehospital setting. Annals of Emergency Medicine 46(2): 214
Wang, H.E.; Davis, D.P.; O'Connor, R.E.; Domeier, R.M. 2006: Drug-assisted intubation in the prehospital setting (resource document to NAEMSP position statement). Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 10(2): 261-271
Anonymous 2006: Drug-assisted intubation in the prehospital setting position statement of the National Association of Emergency Physicians. Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 10(2): 260
Mann, H.J. 2006: Drug-associated disease: cytochrome P450 interactions. Critical Care Clinics 22(2): 329-345 Vii
Vandendries, E.R.; Drews, R.E. 2006: Drug-associated disease: hematologic dysfunction. Critical Care Clinics 22(2): 347-355 Viii
Eggerath, J.; English, H.; Leichter, J.W. 2005: Drug-associated gingival enlargement: case report and review of aetiology, management and evidence-based outcomes of treatment. Journal of the New Zealand Society of Periodontology 2005(88): 7-14
Mayaud, C.; Fartoukh, M.; Parrot, A.; Cadranel, J.; Milleron, B.; Akoun, G. 2005: Drug-associated interstitial lung disease: a diagnostic challenge. Revue de Pneumologie Clinique 61(3): 179-185
Dodd, J.D.; Lee, K.S.; Johkoh, T.; Müller, N.L. 2006: Drug-associated organizing pneumonia: high-resolution CT findings in 9 patients. Journal of Thoracic Imaging 21(1): 22-26
Taber, S.S.; Mueller, B.A. 2006: Drug-associated renal dysfunction. Critical Care Clinics 22(2): 357-374 Viii
Sarmati, L.; Nicastri, E.; Uccella, I.; D'Ettorre, G.; Parisi, S.G.; Palmisano, L.; Galluzzo, C.; Concia, E.; Vullo, V.; Vella, S.; Andreoni, M. 2003: Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. Journal of Clinical Microbiology 41(4): 1760-1762
Shader, R.I. 2003: Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion. Journal of Clinical Psychopharmacology 23(6): 533-534
Barton, A.; Barton, M.; Barton, A.; Barton, M. 2005: Drug-based inhibition of pressure ulcers. 1981. Journal of Tissue Viability 15(2): 10-11
Gainotti, A.; Bettini, R.; Gazzaniga, A.; Colombo, P.; Giordano, F. 2004: Drug-beta-cyclodextrin containing pellets prepared with a high-shear mixer. Drug Development and Industrial Pharmacy 30(10): 1061-1068
Sicras, A.; Rejas-Gutiérrez, J. 2004: Drug-cholinesterase-inhibitors persistence patterns in treated patients with dementia of Alzheimer type: retrospective comparative analysis of donepezil, rivastigmine and galantamine. Revista de Neurologia 39(4): 312-316
Tozzi, V.; Zaccarelli, M.; Bonfigli, S.; Lorenzini, P.; Liuzzi, G.; Trotta, M.P.; Forbici, F.; Gori, C.; Bertoli, A.; Bellagamba, R.; Narciso, P.; Perno, C.F.; Antinori, A. 2006: Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Antiviral Therapy 11(5): 553-560
Anonymous 2002: Drug-coated stents. Minimally Invasive Therapy and Allied Technologies: Mitat: Official Journal of the Society for Minimally Invasive Therapy 11(4): 185-192
Anonymous 2004: Drug-coated stents boost benefits of angioplasty. These tiny devices keep unclogged arteries open but don't prevent blockages from arising in other heart arteries. Harvard heart letter: from Harvard Medical School 14(5): 4
Scheller, B. 2004: Drug-coated stents. Where do we stand in 2004?. Zeitschrift für Kardiologie 93(9): 646-648
Stanik-Hutt, J.A. 2004: Drug-coated stents: preventing restenosis in coronary artery disease. Journal of Cardiovascular Nursing 19(6): 404-408
Lambert, J.M. 2005: Drug-conjugated monoclonal antibodies for the treatment of cancer. Current Opinion in Pharmacology 5(5): 543-549
Petrucci, D. 1953: Drug-controlled artificial hibernation and hypothermia. Athena; Rassegna Mensile di Biologia Clinica e Terapia 19(10-11): 368-370
Sakimura, K.; Hiranita, T.; Miyamoto, M.; Nagata, K.; Yamamoto, T. 2005: Drug-craving animal models and mechanisms. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 126(1): 24-29; 23
Muirhead, E.E.; Halden, E.R.; Groves, M. 1958: Drug-dependent Coombs (antiglobulin) test and anemia; observations on quinine and acetophenetidin (phenacetin). A.M.A. Archives of Internal Medicine 101(1): 87-96
González, C.A.; Guzmán, L.; Nocetti, G. 2003: Drug-dependent antibodies with immune hemolytic anemia in AIDS patients. Immunohematology 19(1): 10-15
Liebendorfer, G. 1953: Drug-determined complications in a case of jugular vein thrombosis. Hno 4(1): 23-24
Sipkoff, M. 2005: Drug-development process already subject to oversight. Managed Care 14(1): 78; 80-81
Mross, K.; Steinbild, S.; Baas, F.; Reil, M.; Buss, P.; Mersmann, S.; Voliotis, D.; Schwartz, B.; Brendel, E. 2003: Drug-drug interaction pharmacokinetic study with the Raf kinase inhibitor (RKI) BAY 43-9006 administered in combination with irinotecan (CPT-11) in patients with solid tumors. International Journal of Clinical Pharmacology and Therapeutics 41(12): 618-619
Bhutani, H.; Singh, S.; Jindal, K.C. 2005: Drug-drug interaction studies on first-line anti-tuberculosis drugs. Pharmaceutical Development and Technology 10(4): 517-524
Li Wan Po, A. 2005: Drug-drug interactions and adverse drug reactions: the bollards and flashing lights syndrome. Journal of Clinical Pharmacy and Therapeutics 30(2): 97-99
Trifiro, G. 2006: Drug-drug interactions and statin therapy. Southern Medical Journal 99(12): 1325-1326
Kashuba, A.D.M. 2005: Drug-drug interactions and the pharmacotherapy of HIV infection. Topics in HIV Medicine: a Publication of the International Aids Society Usa 13(2): 64-69
Di Perri, G.; Aguilar Marucco, D.; Mondo, A.; Gonzalez de Requena, D.; Audagnotto, S.; Gobbi, F.; Bonora, S. 2005: Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy. Expert Opinion on Drug Safety 4(5): 821-836
Wilting, I.; Movig, K.L.; Moolenaar, M.; Hekster, Y.A.; Brouwers, J.R.; Heerdink, E.R.; Nolen, W.A.; Egberts, A.C. 2005: Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disorders 7(3): 274-280
Conley, R.R.; Kelly, D.L. 2007: Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients. Psychopharmacology Bulletin 40(1): 77-97
Hanlon, J.T.; Schmader, K.E. 2005: Drug-drug interactions in older adults: which ones matter?. American Journal of Geriatric PharmacoTherapy 3(2): 61-63
Blower, P.; de Wit, R.; Goodin, S.; Aapro, M. 2005: Drug-drug interactions in oncology: why are they important and can they be minimized?. Critical Reviews in Oncology/Hematology 55(2): 117-142
Bates, E.R.; Mukherjee, D.; Lau, W.C. 2003: Drug-drug interactions involving antiplatelet agents. European Heart Journal 24(19): 1707-1709
Li, M.; Anderson, G.D.; Wang, J. 2006: Drug-drug interactions involving membrane transporters in the human kidney. Expert Opinion on Drug Metabolism and Toxicology 2(4): 505-532
Gubbins, P.O.; Amsden, J.R. 2005: Drug-drug interactions of antifungal agents and implications for patient care. Expert Opinion on PharmacoTherapy 6(13): 2231-2243
Back, D.J. 2006: Drug-drug interactions that matter. Topics in HIV Medicine: a Publication of the International Aids Society Usa 14(2): 88-92
Morales-Olivas, F.J.; Estañ, L. 2006: Drug-drug interactions. An update. Medicina Clinica 127(7): 269-275
Preskorn, S.H. 2005: Drug-drug interactions: Proof of relevance (Part II): cause of tolerability problems or noncompliance. Journal of Psychiatric Practice 11(6): 397-401
Juárez Giménez, J.Carlos.; Montoro Ronsano, Jé.Bruno. 2007: Drug-drug interactions: new aspects. Medicina Clinica 128(1): 38; Author Reply 38-9
Preskorn, S.H. 2005: Drug-drug interactions: proof of relevance (part I). Journal of Psychiatric Practice 11(2): 116-122
Sandson, N. 2005: Drug-drug interactions: the silent epidemic. Psychiatric Services 56(1): 22-24
Juurlink, D.N. 2004: Drug-drug interactions: where do we go from here?. Journal of the American Pharmacists Association: Japha 44(2): 128; 131
Duda, S.H.; Bosiers, M.; Lammer, J.; Scheinert, D.; Zeller, T.; Oliva, V.; Tielbeek, A.; Anderson, J.; Wiesinger, B.; Tepe, G.; Lansky, A.; Jaff, M.R.; Mudde, C.; Tielemans, H.; Beregi, J.-P. 2006: Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 13(6): 701-710
Di Mario, C.; Griffiths, H.; Goktekin, O.; Peeters, N.; Verbist, J.; Bosiers, M.; Deloose, K.; Heublein, B.; Rohde, R.; Kasese, V.; Ilsley, C.; Erbel, R. 2004: Drug-eluting bioabsorbable magnesium stent. Journal of Interventional Cardiology 17(6): 391-395
Uurto, I.; Mikkonen, J.; Parkkinen, J.; Keski-Nisula, L.; Nevalainen, T.; Kellomäki, M.; Törmälä, P.; Salenius, J.-P. 2005: Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study. Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists 12(3): 371-379
Knudsen, B.E.; Chew, B.H.; Denstedt, J.D. 2005: Drug-eluting biomaterials in urology: the time is ripe. Bju International 95(6): 726-727
Zilberman, M.; Eberhart, R.C. 2006: Drug-eluting bioresorbable stents for various applications. Annual Review of Biomedical Engineering 8: 153-180
Alarcón, J.A.; Arribas, J.M.; Ruiz, V. 2005: Drug-eluting coronary stents. New England Journal of Medicine 353(22): 2404-2408; Author Reply 2404-2408
Salam, A.M.; Al Suwaidi, J.; Holmes, D.R. 2006: Drug-eluting coronary stents. Current Problems in Cardiology 31(1): 8-119
Curfman, G.D.; Morrissey, S.; Jarcho, J.A.; Drazen, J.M. 2007: Drug-eluting coronary stents--promise and uncertainty. New England Journal of Medicine 356(10): 1059-1060
Knudtson, M.L. 2007: Drug-eluting coronary stents: faith and hope, but no charity. Cmaj: Canadian Medical Association Journal 176(2): 195-196
Bhatia, V.; Bhatia, R.; Dhindsa, S. 2003: Drug-eluting intra-coronary stents: have we got the magic bullet?. Journal of Postgraduate Medicine 49(3): 291-296
Er, F.; Erdmann, E. 2007: Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice. Medizinische Klinik 102(1): 30-32
Cutlip, D.E. 2006: Drug-eluting stent era: will we improve 5-year outcomes?. Coronary Artery Disease 17(8): 681-684
Kang, W.Y.; Kim, W.; Kim, H.G.; Kim, W. 2007: Drug-eluting stent fracture occurred within 2 days after stent implantation. International Journal of Cardiology 120(2): 273-275
Kakkar, A.K.; Fischi, M.; Narins, C.R. 2006: Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 68(1): 118-122; Discussion: 123-124
Novaro, G.M.; Cherla, A.; Fromkin, K.R.; Bush, H.S. 2007: Drug-eluting stent implantation in ST-elevation acute myocardial infarction: 'real world' 30-day and mid-term results. Cardiovascular Revascularization Medicine: Including Molecular Interventions 8(1): 5-8
Lozano, I.ñi.; Avanzas, P.; Lee, D.-H.; Lasa, G.; Rondán, J.; Moris, C.és. 2007: Drug-eluting stent implantation in bifurcated lesions with balloon-crushing technique and 6 fr guiding catheter: immediate and mid-term results. Journal of Invasive Cardiology 19(1): 27-31
Sheiban, I.; Moretti, C.; Sciuto, F.; Omedè, P.; Grosso Marra, W.; Trevi, G. 2004: Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerations. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 5(8): 638-641
McKenna, C.J. 2004: Drug-eluting stent restenosis rates?. Circulation 109(9): E154
Suzuki, Y.; Ikeno, F.; Yeung, A.C. 2006: Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. Journal of Invasive Cardiology 18(3): 111-114
Migliorini, A.; Moschi, G.; Giurlani, L.; Valenti, R.; Vergara, R.; Parodi, G.; Carrabba, N.; Dovellini, E.V.; Antoniucci, D. 2006: Drug-eluting stent supported percutaneous coronary intervention for unprotected left main disease. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 68(2): 225-230
Hodgson, J.McB.; Bottner, R.K.; Klein, L.W.; Walpole, H.T.; Cohen, D.J.; Cutlip, D.E.; Fenninger, R.B.; Firth, B.G.; Greenberg, D.; Kalisky, I.; Meskan, T.; Powell, W.; Stone, G.W.; Zito, J.P.; Clark, M.Ann. 2004: Drug-eluting stent task force: final report and recommendations of the working committees on cost-effectiveness/economics, access to care, and medicolegal issues. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 62(1): 1-17
Colombo, A.; Corbett, S.J. 2006: Drug-eluting stent thrombosis: increasingly recognized but too frequently overemphasized. Journal of the American College of Cardiology 48(1): 203-205
Di Roio, C.; Gaillac, N.; Pélissou, I.; Carillon, R.; Dailler, F. 2007: Drug-eluting stent, intraventricular haemorrhage, ventricular drainage, favourable outcome. Annales Francaises d'Anesthesie et de Reanimation 26(1): 91-92
Migliorini, A.; Moschi, G.; Vergara, R.; Parodi, G.; Carrabba, N.; Antoniucci, D. 2006: Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 67(3): 344-348
Htay, T.; Liu, M.W. 2005: Drug-eluting stent: a review and update. Vascular Health and Risk Management 1(4): 263-276
Gao, R.-l. 2006: Drug-eluting stent: is it safe?. Zhonghua Xin Xue Guan Bing Za Zhi 34(11): 964-965
Baim, D.S.; Mauri, L.; Cutlip, D.C. 2006: Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery?. Journal of the American College of Cardiology 47(4): 878-881
Lee, M.S.; Shah, A.P.; Aragon, J.; Jamali, A.; Dohad, S.; Kar, S.; Makkar, R.R. 2005: Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 66(4): 507-511
Popma, J.J.; Tulli, M. 2006: Drug-eluting stents. Cardiology Clinics 24(2): 217-231 Vi
Alfonso, F. 2005: Drug-eluting stents and in-stent restenosis. JAMA 293(15): 1855; Author Reply 1855-6
Tsimikas, S. 2006: Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited. Journal of the American College of Cardiology 47(10): 2112-2115
Moreno, R.úl. 2005: Drug-eluting stents and other anti-restenosis devices. Revista Espanola de Cardiologia 58(7): 842-862
McClure, S.; Webb, J. 2004: Drug-eluting stents and saphenous vein graft intervention. Journal of Invasive Cardiology 16(5): 234-235
Raja, S.G. 2006: Drug-eluting stents and the future of coronary artery bypass surgery: facts and fiction. Annals of Thoracic Surgery 81(3): 1162-1171
Hirshfeld, J.W.; Wilensky, R.L. 2004: Drug-eluting stents are here--now what? Implications for clinical practice and health care costs. Cleveland Clinic Journal of Medicine 71(10): 825-828
Sigwart, U. 2006: Drug-eluting stents are safe and effective: right or wrong?. Journal of the American College of Cardiology 47(7): 1361-1362
Fairfield, K.D. 2004: Whose side are you on? Interdependence and its consequences in management of healthcare delivery. Journal of Healthcare Management / American College of Healthcare Executives 49(1): 17-29; Discussion: 30-31
Skyttberg, N.; Linder, R.; Carlsson, J.ör. 2006: Drug-eluting stents can increase the risk of late stent thrombosis. Lakartidningen 103(39): 2845-2847
Alyaev, Y.G.; Sirota, E.S.; Bezrukov, E.A.; Fiev, D.N.; Bukatov, M.D.; Letunovskii, A.V.; Byadretdinov, I.S. 2017: Application of 3D soft print models of the kidney for treatment of patients with localized cancer of the kidney (a pilot study). Urologiia 6: 12-19
Ryan, J.; Cohen, D.J.; Pinto, D.S. 2006: Drug-eluting stents for ST[corrected]-elevation acute myocardial infarction: do we need randomized trials?. Coronary Artery Disease 17(8): 667-671
Granada, J.F.; Kaluza, G.L.; Raizner, A. 2003: Drug-eluting stents for cardiovascular disorders. Current Atherosclerosis Reports 5(4): 308-316
Jørgensen, E.; Kelbaek, H. 2005: Drug-eluting stents for chronic total occlusions make sense, but it is too early to close the discussion. European Heart Journal 26(11): 1049-1051
Ormiston, J.A.; Webster, M.W.I.; El Jack, S.; Ruygrok, P.N.; Stewart, J.T.; Scott, D.; Currie, E.; Panther, M.J.; Shaw, B.; O'Shaughnessy, B. 2006: Drug-eluting stents for coronary bifurcations: bench testing of provisional side-branch strategies. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 67(1): 49-55
Ormiston, J.A.; Currie, E.; Webster, M.W.I.; Kay, P.; Ruygrok, P.N.; Stewart, J.T.; Padgett, R.C.; Panther, M.J. 2004: Drug-eluting stents for coronary bifurcations: insights into the crush technique. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 63(3): 332-336
Simonton, C.A.; Brodie, B.R.; Wilson, B.H. 2005: Drug-eluting stents for emerging treatment strategies in complex lesions. Reviews in Cardiovascular Medicine 6(Suppl 1): S38-S47
Tepe, G. 2006: Drug-eluting stents for infrainguinal occlusive disease: progress and challenges. Seminars in Vascular Surgery 19(2): 102-108
Ong, A.T.L.; van der Giessen, W.J. 2005: Drug-eluting stents for interventional revascularization of coronary multivessel disease. Journal of Interventional Cardiology 18(6): 447-453
Kastrati, A. 2004: Drug-eluting stents for secondary prevention of restenosis. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 63(3): 265-266
Anderson, R.A.; Fath-Ordoubadi, F.; Younas, S.; Bainbridge, A.; Swallow, R.A.; Dawkins, K.D.; Curzen, N.P. 2005: Drug-eluting stents for the treatment of in-stent restenosis--'real world' double centre experience in consecutive patients. International Journal of Cardiovascular Interventions 7(4): 188-192
Yan, B.P.Y.; Ajani, A.E.; Waksman, R. 2005: Drug-eluting stents for the treatment of in-stent restenosis: a clinical review. Cardiovascular Revascularization Medicine: Including Molecular Interventions 6(1): 38-43
Bailey, S.R. 2004: Drug-eluting stents have made brachytherapy obsolete. Current Opinion in Cardiology 19(6): 598-600
Zhang, Q.; Fang, Y.-h.; Zhang, R.-y.; Hu, J.; Yang, Z.-k.; Ni, J.; Zhang, J.-s.; Shen, W.-f. 2006: Drug-eluting stents improve clinical outcomes in Chinese diabetic patients with de novo coronary artery disease. Chinese Medical Journal 119(18): 1576-1579
Van de Werf, F. 2006: Drug-eluting stents in acute myocardial infarction. New England Journal of Medicine 355(11): 1169-1170
Cohen, M.G.; Ohman, E.M. 2005: Drug-eluting stents in acute myocardial infarction: is science catching up with practice?. JAMA 293(17): 2154-2156
Assali, A.R.; Assa, H.V.; Ben-Dor, I.; Teplitsky, I.; Solodky, A.; Brosh, D.; Fuchs, S.; Kornowski, R. 2006: Drug-eluting stents in bifurcation lesions: to stent one branch or both?. Catheterization and Cardiovascular Interventions: Official Journal of the Society for Cardiac Angiography and Interventions 68(6): 891-896
Tornvall, P. 2004: Drug-eluting stents in coronary arteries. The risk of restenosis is drastically reduced. Lakartidningen 101(51-52): 4175
Lozano, I.ñi.; Herrera, C.; Morís, C.és.; Gómez-Hospital, J.A.; Rondán, J.; Iráculis, E.; Martín, M.ía.; Cequier, A.; Suárez, E.; Esplugas, E. 2005: Drug-eluting stents in patients with left main coronary lesions who are not candidates for surgical revascularization. Revista Espanola de Cardiologia 58(2): 145-152
Ellozy, S.H.; Carroccio, A. 2003: Drug-eluting stents in peripheral vascular disease: eliminating restenosis. Mount Sinai Journal of Medicine new York 70(6): 417-419
Valgimigli, M.; Percoco, G.; Bolognese, L. 2006: Drug-eluting stents in primary PCI. New England Journal of Medicine 355(23): 2484; Author Reply 2484-2486
Dzavik, V. 2006: Drug-eluting stents in total coronary occlusions: another piece of the puzzle solved?. American Heart Journal 152(5): 807-809
Iwakura, T.; nomoto, S.; Yamamoto, K.; Fujita, T.; Ohira, N.; Sakamoto, T.; Okamura, H. 2006: Drug-eluting stents restenosis 2 months after the procedure and necessitating semi-emergency off-pump coronary artery bypass. Kyobu Geka. Japanese Journal of Thoracic Surgery 59(5): 369-372
Mitka, M. 2004: Drug-eluting stents show promise: but experts warn against enthusiasm outpacing science. JAMA 291(6): 682-683
Morrow, T. 2003: Drug-eluting stents to transform cardiovascular medicine. Managed Care 12(7): 47-50
Ben-Gal, Y.; Mohr, R.; Uretzky, G.; Medalion, B.; Hendler, A.; Hansson, N.; Herz, I.; Moshkovitz, Y. 2006: Drug-eluting stents versus arterial myocardial revascularization in patients with diabetes mellitus. Journal of Thoracic and Cardiovascular Surgery 132(4): 861-866
Conti, C.R. 2003: Drug-eluting stents versus bare metal stents. Clinical Cardiology 26(11): 493-494
Indolfi, C.; Pavia, M.; Angelillo, I.F. 2005: Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis). American Journal of Cardiology 95(10): 1146-1152
Herz, I.; Moshkovitz, Y.; Loberman, D.; Uretzky, G.; Braunstein, R.; Hendler, A.; Zivi, E.; Ben-Gal, Y.; Mohr, R. 2005: Drug-eluting stents versus bilateral internal thoracic grafting for multivessel coronary disease. Annals of Thoracic Surgery 80(6): 2086-2090
Ben-Gal, Y.; Moshkovitz, Y.; Nesher, N.; Uretzky, G.; Braunstein, R.; Hendler, A.; Zivi, E.; Herz, I.; Mohr, R. 2006: Drug-eluting stents versus coronary artery bypass grafting in patients with diabetes mellitus. Annals of Thoracic Surgery 82(5): 1692-1697
Chu, W.W.; Torguson, R.; Pichard, A.D.; Satler, L.F.; Chan, R.; Porrazzo, M.; Kent, K.M.; Suddath, W.O.; Waksman, R. 2005: Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation. Journal of Invasive Cardiology 17(12): 659-662
Mizuguchi, H.; Funakoshi, N.; Hosono, T.; Sakurai, F.; Kawabata, K.; Yamaguchi, T.; Hayakawa, T. 2007: Rapid construction of small interfering RNA-expressing adenoviral vectors on the basis of direct cloning of short hairpin RNA-coding DNAs. Human Gene Therapy 18(1): 74-80
Weinberg, S.L. 2004: Drug-eluting stents, evidence-based medicine, and medical uncertainty. American Heart Hospital Journal 2(2): 70-72
Conti, C.R. 2006: Drug-eluting stents--safety concerns. Clinical Cardiology 29(11): 479-480
Chen, T.N.; Yin, X.T.; Li, X.G.; Zhao, J.; Wang, L.; Mu, N.; Ma, K.; Huo, K.; Liu, D.; Gao, B.Y.; Feng, H.; Li, F. 2018: Application of 3D virtual reality technology with multi-modality fusion in resection of glioma located in central sulcus region. Zhonghua Yi Xue Za Zhi 98(17): 1302-1305
Saia, F.; Marzocchi, A.; Serruys, P.W. 2005: Drug-eluting stents. the third revolution in percutaneous coronary intervention. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(4): 289-303
Burt, H.M.; Hunter, W.L. 2006: Drug-eluting stents: a multidisciplinary success story. Advanced Drug Delivery Reviews 58(3): 350-357
Boudoulas, H. 2006: Drug-eluting stents: a state of uncertainty. Hellenic Journal of Cardiology: Hjc 47(6): 386-387
Burt, H.M.; Hunter, W.L. 2006: Drug-eluting stents: an innovative multidisciplinary drug delivery platform. Advanced Drug Delivery Reviews 58(3): 345-346
Virmani, R.; Kolodgie, F.D.; Farb, A. 2004: Drug-eluting stents: are they really safe?. American Heart Hospital Journal 2(2): 85-88
Hunter, W.L. 2006: Drug-eluting stents: beyond the hyperbole. Advanced Drug Delivery Reviews 58(3): 347-349
Rogers, C.D.K. 2005: Drug-eluting stents: clinical perspectives on drug and design differences. Reviews in Cardiovascular Medicine 6(Suppl 1): S3-12
Ong, A.T.L.; Serruys, P.W. 2005: Drug-eluting stents: current issues. Texas Heart Institute Journal 32(3): 372-377
Nordmann, A. 2006: Drug-eluting stents: do they keep their promises?. Praxis 95(15): 581-583
Sindermann, Jürgen.R.; Plenz, G.; Breithardt, Günter. 2004: Drug-eluting stents: do we know enough about safety?. Circulation 109(3): E22
Lázaro y de Mercado, P. 2004: Drug-eluting stents: efficacy, effectiveness, efficiency and evidence. Revista Espanola de Cardiologia 57(7): 608-612
Yang, C.; Burt, H.M. 2006: Drug-eluting stents: factors governing local pharmacokinetics. Advanced Drug Delivery Reviews 58(3): 402-411
Waksman, R. 2002: Drug-eluting stents: from bench to bed. Cardiovascular Radiation Medicine 3(3-4): 226-241
Marchetti, M. 2004: Drug-eluting stents: from evidence to policy. Expert Review of Medical Devices 1(1): 49-63
Saia, F.; Degertekin, M.; Lemos, P.A.; Serruys, P.W. 2004: Drug-eluting stents: from randomized trials to the real world. Minerva Cardioangiologica 52(5): 349-363
Sangiorgi, G.; Rodamni, P.; Airoldi, F.; Colombo, A. 2005: Drug-eluting stents: from the results of clinical studies to economic simulation models in the Italian reality. Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(3): 145-156
Korovesis, S.; Karvouni, E.; Giazitzoglou, E.; Katritsis, D. 2005: Drug-eluting stents: immediate and long-term results. Hellenic Journal of Cardiology: Hjc 46(5): 330-335
Chevalier, B.; Blanchard, D.; Berland, J.; Carrié, D.; Gilard, M.; Hanssen, M.; Louvard, Y.; Eltchaninoff, H. 2005: Drug-eluting stents: indications, limits and future development. Archives des Maladies du Coeur et des Vaisseaux 98(10): 1013-1021
Raja, S.G. 2004: Drug-eluting stents: is it the beginning of the end for coronary artery bypass surgery?. Chinese Medical Journal 117(9): 1377-1387
Scheen, Aé.J.; Warzée, F.; Legrand, V.M.G. 2004: Drug-eluting stents: meta-analysis in diabetic patients. European heart journal 25(23): 2167-8; author reply 2168-9
Duda, S.H.; Poerner, T.C.; Wiesinger, B.; Rundback, J.H.; Tepe, G.; Wiskirchen, J.; Haase, K.K. 2003: Drug-eluting stents: potential applications for peripheral arterial occlusive disease. Journal of Vascular and Interventional Radiology: Jvir 14(3): 291-301
Slavin, L.; Chhabra, A.; Tobis, J.M. 2007: Drug-eluting stents: preventing restenosis. Cardiology in Review 15(1): 1-12
Eisenberg, M.J. 2004: Drug-eluting stents: some bare facts. Lancet 364(9444): 1466-1467
Murphy, B.E. 2004: Drug-eluting stents: some first-generation problems. American Heart Hospital Journal 2(2): 80-84
Colombo, A.; Iakovou, I. 2004: Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation. European Heart Journal 25(11): 895-897
Lim, M.C.L. 2004: Drug-eluting stents: the panacea for restenosis?. Singapore Medical Journal 45(7): 300-302
Eisenberg, M.J. 2006: Drug-eluting stents: the price is not right. Circulation 114(16): 1745-1754; Discussion 1754
Presbitero, P.; Zavalloni, D.; Rossi, M.L.; Pagnotta, P.; Belli, G.; Gasparini, G.L.; Corrada, E.; Milone, F. 2006: Drug-eluting stents: towards new endpoints. Minerva Cardioangiologica 54(5): 521-537
Guagliumi, G.; Virmani, R.; Musumeci, G.; Motta, T.; Valsecchi, O.; Bonaldi, G.; Saino, A.; Tespili, M.; Greco, N.ò; Farb, A. 2003: Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(10): 713-720
Isenbarger, D.W.; Resar, J.R. 2005: Drug-eluting versus third-generation bare metal stents: the US strategy. International Journal of Cardiovascular Interventions 7(4): 171-175
Altshuler, S.J. 2005: Drug-endangered children need a collaborative community response. Child Welfare 84(2): 171-190
Mettner, J. 2005: Drug-error detectives. Minnesota Medicine 88(10): 6-7
Wyttenbach, N.; Birringer, C.; Alsenz, J.; Kuentz, M. 2005: Drug-excipient compatibility testing using a high-throughput approach and statistical design. Pharmaceutical Development and Technology 10(4): 499-505
Cybulska, B. 2002: Drug-facilitated rape. Journal of Family Planning and Reproductive Health Care 28(3): 125
Kintz, P.; Villain, M.; Dumestre-Toulet, V.ér.; Ludes, B. 2005: Drug-facilitated sexual assault and analytical toxicology: the role of LC-MS/MS a case involving zolpidem. Journal of Clinical Forensic Medicine 12(1): 36-41
Puri, B.K. 2007: Drug-facilitated sexual assaults. International Journal of Clinical Practice 61(2): 184-185
Anonymous 2006: Drug-free help for an aching back. Johns Hopkins Medical Letter Health After 50 18(8): 3 7
Anonymous 2005: Drug-free relapse prevention. Harvard Mental Health Letter 21(9): 7
Schelleman, H.; Klungel, O.H.; van Duijn, C.M.; Witteman, J.C.M.; Hofman, A.; de Boer, A.; Stricker, B.H.Ch. 2006: Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. Annals of PharmacoTherapy 40(2): 212-218
Brazier, N.C.; Levine, M.A.H. 2003: Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. American Journal of Therapeutics 10(3): 163-169
Huntley, A. 2004: Drug-herb interactions with herbal medicines for menopause. Journal of the British Menopause Society 10(4): 162-165
Hackett, A.M. 2003: Drug-impaired driving: new resources in understanding the problem. Annals of Emergency Medicine 42(6): 811
Chwalla, R. 1960: Drug-induced (iatrogenic) urinary retention and its treatment. Wiener Medizinische Wochenschrift 110: 895-897
Roberts-Thomson, K.C.; Teo, K.S.L.; Young, G.D. 2007: Drug-induced Brugada syndrome with ST-T wave alternans and long QT. Internal Medicine Journal 37(3): 199-200
Saibara, T.; Onishi, S. 2006: Drug-induced NASH. Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1100-1105
Del Giudice, P. 2007: Drug-induced Pseudomonas aeruginosa ecthyma gangrenosum. Journal of the European Academy of Dermatology and Venereology: Jeadv 21(2): 289
Letsas, K.P.; Sideris, A.; Kounas, S.P.; Efremidis, M.; Korantzopoulos, P.; Kardaras, F. 2006: Drug-induced QT interval prolongation after ciprofloxacin administration in a patient receiving olanzapine. International Journal of Cardiology 109(2): 273-274
Shah, R.R. 2005: Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studies. Novartis Foundation Symposium 266: 251-280; Discussion: 280-285
Wooten, J.M. 2006: Drug-induced QT prolongation. Southern Medical Journal 99(1): 16
Dubrey, S.W.; Grocott-Mason, R. 2007: Drug-induced QT prolongation: consequences and current dilemma. British Journal of Hospital Medicine 68(1): 50-51
Sáez, M.; García-Bustínduy, M.; Noda, A.; Dorta, S.; Escoda, M.; Fagundo, E.; Rodríguez, F.; Guimerá, F.; Sánchez, R.; García-Montelongo, R. 2004: Drug-induced Sweet's syndrome. Journal of the European Academy of Dermatology and Venereology: Jeadv 18(2): 233
Kaszala, K.; Kenigsberg, D.N.; Krishnan, S.C. 2006: Drug-induced T wave alternans. Journal of Cardiovascular Electrophysiology 17(3): 332
Lachkar, Y.; Bouassida, W. 2007: Drug-induced acute angle closure glaucoma. Current Opinion in Ophthalmology 18(2): 129-133
Van Heyningen, C. 2005: Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe. Annals of Clinical Biochemistry 42(Part 5): 402-404
Danan, G. 2003: Drug-induced acute hepatic injury. what is the value of diagnostic scales?. Gastroenterologie Clinique et Biologique 27(5 Suppl): B21-B25
Nielsen, P.E. 1963: Drug-induced agranulocytosis after the use of metamizol. Nordisk Medicin 69: 174-175
Favalli, E.G.; Varenna, M.; Sinigaglia, L. 2005: Drug-induced agranulocytosis during treatment with infliximab in enteropathic spondyloarthropathy. Clinical and Experimental Rheumatology 23(2): 247-250
Mosyagin, I.; Cascorbi, I.; Schaub, R.; Krüger, T.; Dettling, M. 2005: Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?. Journal of Clinical Psychopharmacology 25(5): 435-440
Babu, K.S.; Marshall, B.G. 2004: Drug-induced airway diseases. Clinics in Chest Medicine 25(1): 113-122
Zeh, E.; Klaus, D. 1962: Drug-induced allergic myocarditis. Die Medizinische Welt 24: 1355-1358
Giarman, N.J.; Schanberg, S.M. 1962: Drug-induced alterations of the sub-cellular distribution of 5-hydroxytryptamine (serotonin) in rat's brain. Biochemical Pharmacology 9: 93-96
Reder, L.M.; Oates, J.M.; Thornton, E.R.; Quinlan, J.J.; Kaufer, A.; Sauer, J. 2006: Drug-induced amnesia hurts recognition, but only for memories that can be unitized. Psychological Science 17(7): 562-567
Chun, M.M. 2005: Drug-induced amnesia impairs implicit relational memory. Trends in Cognitive Sciences 9(8): 355-357
Flores-Suárez, L.F.; Morales, H.; Angeles, A.; Kraus, A. 2002: Drug-induced amyopathic dermatomyositis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 8(1): 50-54
White, H.R. 1960: Drug-induced anaphylactic reactions in clinical medicine. Bulletin of the School of Medicine 45: 55-66
Leone, R.; Conforti, A.; Venegoni, M.; Motola, D.; Moretti, U.; Meneghelli, I.; Cocci, A.; Sangiorgi Cellini, G.; Scotto, S.; Montanaro, N.; Velo, G. 2005: Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database. Drug Safety 28(6): 547-556
Smalling, R.; Foote, M.; Molineux, G.; Swanson, S.J.; Elliott, S. 2004: Drug-induced and antibody-mediated pure red cell aplasia: a review of literature and current knowledge. Biotechnology Annual Review 10: 237-250
Camus, P.; Bonniaud, P.; Fanton, A.; Camus, C.; Baudaun, N.; Foucher, P. 2004: Drug-induced and iatrogenic infiltrative lung disease. Clinics in Chest Medicine 25(3): 479-519 Vi
Hütteroth, T.H. 2005: Drug-induced and toxic liver diseases. Deutsche Medizinische Wochenschrift 130(Suppl 5): S226-S228
Guis, S.; Mattéi, J.-P.; Lioté, F.éd.ér. 2003: Drug-induced and toxic myopathies. Best Practice and Research. Clinical Rheumatology 17(6): 877-907
Odell, M.S. 1998: Drug-induced anisocoria in two detainees. Journal of Clinical Forensic Medicine 5(1): 10-12
Huczek-Glebocki, J.; Osterczy, Z. 1959: Drug-induced aplastic anemia complicated by diabetes mellitus during prednisone therapy. Polski Tygodnik Lekarski 14: 1662-1664
Lebon, J.; Messerschmitt, J. 1955: Drug-induced aplastic myelosis; terminal acute myeloblstosis; pathogenic reflections. Le Sang 26(8): 799-804
Kanazawa, R.; Yoshida, D.; Takahashi, H.; Sugisaki, Y.; Suzuki, S.; Teramoto, A. 2004: Drug-induced apoptosis by a matrix metalloproteinase inhibitor, SI-27 on human malignant glioma cell lines; in vitro study. Journal of Neuro-Oncology 66(1-2): 91-99
Darpö, Börje. 2006: Drug-induced arrhythmia a difficult to catch adverse effect. New guidelines for increased cardiovascular safety. Lakartidningen 103(14): 1094-1095
Kepa, L.; Oczko-Grzesik, B.; Stolarz, W.; Sobala-Szczygiel, B. 2005: Drug-induced aseptic meningitis in suspected central nervous system infections. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 12(5): 562-564
Diaz-Hurtado, M.; Vidal-Tolosa, A. 2006: Drug-induced aseptic meningitis: a physician's challenge. Journal of the National Medical Association 98(3): 457
Pichler, W.J. 2003: Drug-induced autoimmunity. Current Opinion in Allergy and Clinical Immunology 3(4): 249-253
Olsen, N.J. 2004: Drug-induced autoimmunity. Best Practice and Research. Clinical Rheumatology 18(5): 677-688
Santodomingo-Rubido, J.; Gilmartin, B.; Wolffsohn, J.S. 2003: Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine. Ophthalmic and Physiological Optics: the Journal of the British College of Ophthalmic Opticians 23(6): 567-570
Brinkmeier, T.; Herbst, R.A.; Schaller, J.; Kuegler, K.; Pirker, C.; Beiteke, U.; Grosshans, E.; Frosch, P.J. 2004: Drug-induced blaschkitis. Acta Dermato-Venereologica 84(4): 314-315
Heinivaara, O. 1962: Drug-induced blood changes. Duodecim; Laaketieteellinen Aikakauskirja 78: 292-296
Chalmers, J.N.M. 1952: Drug-induced blood disease. Practitioner 168(1005): 235-242
Epler, G.R. 2004: Drug-induced bronchiolitis obliterans organizing pneumonia. Clinics in Chest Medicine 25(1): 89-94
Ferris, L.K.; Jukic, D.; English, J.C.; Zirwas, M.J. 2005: Drug-induced bullous pemphigoid caused by a generic Canadian medication obtained over the internet. Archives of Dermatology 141(11): 1474-1476
Borch, J.E.; Andersen, K.E.; Clemmensen, O.; Bindslev-Jensen, C. 2005: Drug-induced bullous pemphigoid with positive patch test and in vitro IgE sensitization. Acta Dermato-Venereologica 85(2): 171-172
Mondini, P.; Zaccarini, C.; Porro, A.; Ziliotto, P.; Cavalloni, L. 1956: Drug-induced cardiac arrest in bloodless endocardial surgery. Acta Chirurgica Italica 12(1): 43-62
Madsen, S. 2006: Drug-induced cardiomyopathy. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 126(10): 1340
Hollander, D.A.; Aldave, A.J. 2004: Drug-induced corneal complications. Current Opinion in Ophthalmology 15(6): 541-548
Amerio, P.; Innocente, C.; Feliciani, C.; Angelucci, D.; Gambi, D.; Tulli, A. 2006: Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine. European journal of dermatology: EJD 16(3): 281-283
Bernard, J. 1963: Drug-induced cytopenias. Anatomoclinical study of lesions of the hematopoietic organs and blood. Marseille Medical 100: 433-446
Szekeres, L.ás.ó 2005: Drug-induced delayed cardiac protection against the effects of myocardial ischemia. Pharmacology and Therapeutics 108(3): 269-280
Williams, C.; Highet, A.S. 2006: Drug-induced delayed multiorgan hypersensitivity (DIDMOHS). Clinical and Experimental Dermatology 31(3): 481-482
Swick, B.L.; Walling, H.W. 2005: Drug-induced delusions of parasitosis during treatment of Parkinson's disease. Journal of the American Academy of Dermatology 53(6): 1086-1087
Ayd, F.J. 1958: Drug-induced depression; fact of fallacy. New York State Journal of Medicine 58(3): 354-356
Tăranu, T.; Covic, A.; Buhăescu, I.; Tăranu, T. 2005: Drug-induced dermatological pathology in renal transplantation patients. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 109(1): 36-39
Otake, Y.; Sengupta, T.K.; Bandyopadhyay, S.; Spicer, E.K.; Fernandes, D.J. 2004: Drug-induced destabilization of bcl-2 mRNA: a new approach for inducing apoptosis in tumor cells. Current Opinion in Investigational Drugs 5(6): 616-622
Izzedine, H.; Launay-Vacher, V.; Deybach, C.; Bourry, E.; Barrou, B.; Deray, G. 2005: Drug-induced diabetes mellitus. Expert Opinion on Drug Safety 4(6): 1097-1109
Scheen, A.J.; De Hert, M. 2005: Drug-induced diabetes mellitus: the exemple of atypical antipsychotics. Revue Medicale de Liege 60(5-6): 455-460
Schwarz, M.I.; Fontenot, A.P. 2004: Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis. Clinics in Chest Medicine 25(1): 133-140
Wang, H.-y. 2003: Drug-induced diseases and proper use of drugs. Zhonghua Nei Ke Za Zhi 42(4): 257
Carlson, G.A.; Mick, E. 2003: Drug-induced disinhibition in psychiatrically hospitalized children. Journal of Child and Adolescent Psychopharmacology 13(2): 153-163
Kaizu, K.; Abe, M. 2005: Drug-induced edema. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(1): 102-106
Gylling, H.; Miettinen, T.A. 2006: Drug-induced effects on cholesterol catabolism and bile acids. Current Opinion in Investigational Drugs 7(3): 214-218
Ma, R.C.W.; Kong, A.P.S.; Chan, N.; Tong, P.C.Y.; Chan, J.C.N. 2007: Drug-induced endocrine and metabolic disorders. Drug Safety 30(3): 215-245
Frame, H.F.; Short, D.W. 1955: Drug-induced enteritis. Lancet 268(6861): 434-435
Ghislain, P-Dominique.; Bodarwe, A-Dominique.; Vanderdonckt, O.; Tennstedt, D.; Marot, L.; Lachapelle, J-Marie. 2004: Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome. Acta Dermato-Venereologica 84(1): 65-68
Schleinitz, N.; Veit, V.ér.; Coso, D.; Aurran, T.ér.ès.; Berbis, P.; Harle, J.-R. 2005: Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?. Archives of Dermatology 141(3): 395-396
Allen, J.N. 2004: Drug-induced eosinophilic lung disease. Clinics in Chest Medicine 25(1): 77-88
Souza, C.A.; Müller, N.L.; Johkoh, T.; Akira, M. 2006: Drug-induced eosinophilic pneumonia: high-resolution CT findings in 14 patients. Ajr. American Journal of Roentgenology 186(2): 368-373
Mara, C.; Sarrot-Reynauld, F.; Mallaret, M.; Raclot-Roy, N.; Massot, C. 2004: Drug-induced eruption after treatment of hyperkeratotic crusted scabies with ivermectin. La Revue de Medecine Interne 25(6): 476-477
Schlienger, R.G.; Bircher, A.J. 2003: Drug-induced erythroderma with high fever--is it drug hypersensitivity syndrome?. Journal of Dermatology 30(4): 344-345; Discussion 345
O'Neill, J.L.; Remington, T.L. 2003: Drug-induced esophageal injuries and dysphagia. Annals of PharmacoTherapy 37(11): 1675-1684
Anonymous 2004: Drug-induced esophageal ulceration. Prescrire International 13(71): 104-105
Naess, K. 1957: Drug-induced euphoria and habituation; definitions and use of these terms. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 77(7): 303-304
Daghir, A.; Anand, P.; Gabra, H.; Elliot, D. 2006: Drug-induced exacerbation of glomus tumour pain. Journal of Hand Surgery 31(6): 692
Meller, S.; Erhardt, A.; Auci, A.; Neumann, N.J.; Homey, B. 2003: Drug-induced exanthema caused by pegylated interferon-alpha 2b. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 54(10): 992-993
Mcgeer, P.L.; Boulding, J.E.; Gibson, W.C.; Foulkes, R.G. 1961: Drug-induced extrapyramidal reactions. Treatment with diphenhydramine hydrochloride and dihydroxyphenylalanine. JAMA 177: 665-670
McCulloch, C.A. 2004: Drug-induced fibrosis: interference with the intracellular collagen degradation pathway. Current Opinion in Drug Discovery and Development 7(5): 720-724
Gospodinova, V. 1957: Drug-induced fluctuations of ketosteroid patterns; practical importance. Izvestiia Na Meditsinskite Instituti. Bulletin des Instituts de Medecine . Bulgarska Akademiia Na Naukite. Otdelenie Za Biologicheski i Meditsinski Nauki 14: 29-60
Varnfield, M.; Botha, S.J. 2000: Drug-induced gingival hyperplasia--a review. Sadj: Journal of the South African Dental Association 55(11): 632-641
Kataoka, M.; Kido, J.-i.; Shinohara, Y.; Nagata, T. 2005: Drug-induced gingival overgrowth--a review. Biological and Pharmaceutical Bulletin 28(10): 1817-1821
Izzedine, H.; Launay-Vacher, V.; Bourry, E.; Brocheriou, I.; Karie, S.; Deray, G. 2006: Drug-induced glomerulopathies. Expert Opinion on Drug Safety 5(1): 95-106
Dalal, B.I.; Kollmannsberger, C. 2005: Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency. British Journal of Haematology 129(3): 291
Hutchison, H.E.; Jackson, J.M.; Cassidy, P. 1963: Drug-induced haemolytic anaemia in dermatitis herpetiformis. the importance of Heinz bodies in its recognition. British Journal of Dermatology 75: 161-166
Young, W.B. 2004: Drug-induced headache. Neurologic Clinics 22(1): 173-184
Croissant, B.; Brosi, K.; Hermann, D.; Mann, K. 2004: Drug-induced headache and pain reduction medication with amitriptyline in an 11-year old pupil. Der Nervenarzt 75(5): 489-491
Heinz, A.; Denke, C.; Ernst, G. 1999: Drug-induced headache--pathomechanisms of addiction. Schmerz 13(5): 304-314
Libersa, C.; Gautier, S.; Said, N.A.; Ferez, L.; Caron, J. 2004: Drug-induced heart failure (excluding that caused by anthracyclines). Therapie 59(1): 127-142
Olsson, R.; Brunlöf, G.; Johansson, M.-L.; Persson, M. 2003: Drug-induced hepatic injury in Sweden. Hepatology 38(2): 531-532
Knight, J.A. 1961: Drug-induced hepatic injury: Marplan hepatitis. American Journal of Psychiatry 118: 73-74
Kaymakoğlu, S. 2004: Drug-induced hepatitis, drug-induced autoimmunity or classical autoimmune hepatitis: how can we differentiate?. Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology 15(3): 123-125
Juurlink, D.N. 2003: Drug-induced hepatotoxicity. New England Journal of Medicine 349(20): 1974-1976; Author Reply 1974-1976
Maddrey, W.C. 2005: Drug-induced hepatotoxicity: 2005. Journal of Clinical Gastroenterology 39(4 Suppl 2: S83-S89
Chodorowska, G.; Czelej, D. 2003: Drug-induced hyperergic vasculitis--activity of selected cytokines and acute phase proteins in plasma. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 58(1): 43-47
Petit, A.; Piednoir, Dée.; Germain, M-Laure.; Trenque, T. 2003: Drug-induced hyperprolactinemia: a case-non-case study from the national pharmacovigilance database. Therapie 58(2): 159-163
Hashizume, H.; Takigawa, M. 2005: Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells. Acta Dermato-Venereologica 85(1): 47-50
Komura, K.; Hasegawa, M.; Hamaguchi, Y.; Yukami, T.; Nagai, M.; Yachie, A.; Sato, S.; Takehara, K. 2005: Drug-induced hypersensitivity syndrome associated with human herpesvirus 6 and cytomegalovirus reactivation. Journal of Dermatology 32(12): 976-981
Mahé, E.; Bodemer, C.; Dupic, L.; Hubert, P.; Lacaille, F.; Goulet, O.; Leruez-Ville, M.; Fraitag, S. 2004: Drug-induced hypersensitivity syndrome associated with primary Epstein-Barr virus and human herpesvirus 6 infections in a child intestinal transplant recipient. Transplantation 77(3): 479-480
Criado, P.R.; Criado, R.F.J.; Vasconcellos, C.; Pegas, J.R.P.; Cera, P.íc.C. 2004: Drug-induced hypersensitivity syndrome due to anticonvulsants in a two-year-old boy. Journal of Dermatology 31(12): 1009-1013
Sekiguchi, A.; Kashiwagi, T.; Ishida-Yamamoto, A.; Takahashi, H.; Hashimoto, Y.; Kimura, H.; Tohyama, M.; Hashimoto, K.; Iizuka, H. 2005: Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. Journal of Dermatology 32(4): 278-281
Yigit, S.; Korkmaz, A.; Sekerel, B. 2005: Drug-induced hypersensitivity syndrome in a premature infant. Pediatric Dermatology 22(1): 71-74
Ratajczak, H.V. 2004: Drug-induced hypersensitivity: role in drug development. Toxicological Reviews 23(4): 265-280
Hadad, E.; Weinbroum, A.A.; Ben-Abraham, R. 2003: Drug-induced hyperthermia and muscle rigidity: a practical approach. European Journal of Emergency Medicine: Official Journal of the European Society for Emergency Medicine 10(2): 149-154
Hamada, T.; Hisatome, I.; Shigemasa, C. 2003: Drug-induced hyperuricemia. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 1): 333-337
Atsmon, J.; Dolev, E. 2005: Drug-induced hypomagnesaemia : scope and management. Drug Safety 28(9): 763-788
Hisatome, I.; Ogino, K.; Igawa, O.; Shigemasa, C. 2003: Drug-induced hypouricemia: pathophysiology and application to the hyperuricemia with life style related disease. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 1): 403-409
Garratty, G. 1985: Drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests. Immunohematology 2(1): 1-8
Warkentin, T.E. 2007: Drug-induced immune-mediated thrombocytopenia--from purpura to thrombosis. New England Journal of Medicine 356(9): 891-893
Heeneman, S.; Donners, M.M.P.C.; Bai, L.; Daemen, M.J.A.P. 2007: Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?. Expert Review of Cardiovascular Therapy 5(2): 345-364
Hayashi, T. 2006: Drug-induced impaired spermatogenesis. Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 2: 326-329
Muftuoglu, O.; Hosal, B.M.; Karel, F.; Zilelioglu, G. 2005: Drug-induced intraocular lens movement and near visual acuity after AcrySof intraocular lens implantation. Journal of Cataract and Refractive Surgery 31(7): 1298-1305
Schmutz, J.-L.; Barbaud, A.; Trechot, P. 2006: Drug-induced lichenoid eruptions. Annales de Dermatologie et de Venereologie 133(4): 409
Daudon, M.; Jungers, P. 2004: Drug-induced lithiasis. Revue Medicale de la Suisse Romande 124(8): 483-490
Spinewine, A.; Schoevaerdts, D.; Mwenge, G.B.; Swine, C.; Dive, A. 2005: Drug-induced lithium intoxication: a case report. Journal of the American Geriatrics Society 53(2): 360-361
Lewis, J.H.; Ahmed, M.; Shobassy, A.; Palese, C. 2006: Drug-induced liver disease. Current Opinion in Gastroenterology 22(3): 223-233
Lazerow, S.K.; Abdi, M.S.; Lewis, J.H. 2005: Drug-induced liver disease 2004. Current Opinion in Gastroenterology 21(3): 283-292
Pishvaian, A.C.; Trope, B.W.; Lewis, J.H. 2004: Drug-induced liver disease in 2003. Current Opinion in Gastroenterology 20(3): 208-219
Hoofnagle, J.H. 2004: Drug-induced liver injury network (DILIN). Hepatology 40(4): 773
Björnsson, E. 2006: Drug-induced liver injury: Hy's rule revisited. Clinical Pharmacology and Therapeutics 79(6): 521-528
Thames, G. 2004: Drug-induced liver injury: what you need to know. Gastroenterology Nursing: the Official Journal of the Society of Gastroenterology Nurses and Associates 27(1): 31-33
Biour, M.; Ben Salem, C.; Chazouillères, O.; Grangé, J-Didier.; Serfaty, L.; Poupon, R. 2004: Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs. Gastroenterologie Clinique et Biologique 28(8-9): 720-759
Kannankeril, P.J.; Roden, D.M. 2007: Drug-induced long QT and torsade de pointes: recent advances. Current Opinion in Cardiology 22(1): 39-43
Chism, S.; Smith, E. 2004: Drug-induced long QT syndrome and Torsade de Pointes. Journal of the Arkansas Medical Society 101(1): 24-26
Clark, G.; Camus, P.; Frey, J.G. 2005: Drug-induced lung disease in general practice. Revue Medicale Suisse 1(23): 1549-1554
Silva, C.I.S.; Müller, N.L. 2006: Drug-induced lung diseases: most common reaction patterns and corresponding high-resolution CT manifestations. Seminars in Ultrasound Ct and Mr 27(2): 111-116
Benucci, M.; Li Gobbi, F.; Fossi, F.; Manfredi, M.; Del Rosso, A. 2005: Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. Journal of Clinical Rheumatology: Practical Reports on Rheumatic and Musculoskeletal Diseases 11(1): 47-49
Antonov, D.; Kazandjieva, J.; Etugov, D.; Gospodinov, D.; Tsankov, N. 2004: Drug-induced lupus erythematosus. Clinics in Dermatology 22(2): 157-166
Wofford, M.R.; King, D.S.; Harrell, T.K. 2006: Drug-induced metabolic syndrome. Journal of Clinical Hypertension 8(2): 114-119
Salamat, A.; Watson, H.G. 2003: Drug-induced methaemoglobinaemia presenting with angina following the use of dapsone. Clinical and Laboratory Haematology 25(5): 327-328
Liley, D.T.J.; Cadusch, P.J.; Gray, M.; Nathan, P.J. 2003: Drug-induced modification of the system properties associated with spontaneous human electroencephalographic activity. Physical Review. E Statistical Nonlinear and Soft Matter Physics 68(5 Part 1): 051906
Lasagna, L.; Von Felsinger, J.M.; Beecher, H.K. 1955: Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts. Journal of the American Medical Association 157(12): 1006-1020
Von Felsinger, J.M.; Lasagna, L.; Beecher, H.K. 1955: Drug-induced mood changes in man. II. Personality and reactions to drugs. Journal of the American Medical Association 157(13): 1113-1119
Rodnitzky, R.L. 2003: Drug-induced movement disorders in children. Seminars in Pediatric Neurology 10(1): 80-87
Rodnitzky, R.L. 2005: Drug-induced movement disorders in children and adolescents. Expert Opinion on Drug Safety 4(1): 91-102
Blayac, J.-P.; Pinzani, V.ér.; Peyrière, H.él.èn.; Hillaire-Buys, D. 2004: Drug-induced movement disorders: tardive syndromes. Therapie 59(1): 113-119
Bowden, D.H.; Goyer, R.A. 1962: Drug-induced muscle necrosis with massive taurinuria. Archives of Pathology 74: 137-141
Bannwarth, B. 2007: Drug-induced musculoskeletal disorders. Drug Safety 30(1): 27-46
Papp, E.; Czopf, L.; Habon, T.; Halmosi, R.; Horvath, B.; Marton, Z.; Tahin, T.; Komocsi, A.; Horvath, I.; Melegh, B.; Toth, K. 2005: Drug-induced myocardial infarction in young patients: report of two cases. International Journal of Cardiology 98(1): 169-170
El Menyar, A.A. 2006: Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. Journal of Postgraduate Medicine 52(1): 51-56
Brefel-Courbon, C.; Gardette, V.; Ory, F.; Montastruc, J.L. 2006: Drug-induced myoclonus: a French pharmacovigilance database study. Neurophysiologie Clinique 36(5-6): 333-336
Anonymous 2003: Drug-induced myopia. Prescrire International 12(63): 22-23
Piraccini, B.M.; Iorizzo, M.; Starace, M.; Tosti, A. 2006: Drug-induced nail diseases. Dermatologic Clinics 24(3): 387-391
Perazella, M.A. 2005: Drug-induced nephropathy: an update. Expert Opinion on Drug Safety 4(4): 689-706
Yang, Y.; Zhou, Z.; Liu, R.; Chen, L.; Xiang, H.; Chen, N. 2018: Application of 3D visualization and 3D printing technology on ERCP for patients with hilar cholangiocarcinoma. Experimental and Therapeutic Medicine 15(4): 3259-3264
Xu, W.; Shi, K.-w.; Yao, X.; Yang, Y.-x.; Lin, Y.-h.; Hu, J. 2016: Application of 3S Techniques to Regional Survey of Chinese Materia Medica Resources. Zhong Yao Cai 39(4): 743-746
Douglas, A.S. 1962: Drug-induced neutropenia and agranulocytosis. Practitioner 188: 202-209
Stack, R.; Tarr, K. 2006: Drug-induced optic neuritis and uveitis secondary to bisphosphonates. New Zealand Medical Journal 119(1230): U1888
Pascussi, J.-M.; Vilarem, M.-J.é 2005: Drug-induced osteomalacia : possible role of PXR, a receptor involved in detoxification. Medecine Sciences: M/S 21(6-7): 582-583
Bosack, R.C. 2005: Drug-induced osteonecrosis of the jaws: a new clinical entity. Cds Review 98(4): 16-17
McMillian, M.; Nie, A.; Parker, J.Brandon.; Leone, A.; Kemmerer, M.; Bryant, S.; Herlich, J.; Yieh, L.; Bittner, A.; Liu, X.; Wan, J.; Johnson, M.D.; Lord, P. 2005: Drug-induced oxidative stress in rat liver from a toxicogenomics perspective. Toxicology and Applied Pharmacology 207(2): 171-178
Biour, M.; Daoud, H.; Ben Salem, C. 2005: Drug-induced pancreatitis. Second edition of the bibliographic database of pancreatitis related to drugs. Gastroenterologie Clinique et Biologique 29(4): 353-359
Trivedi, C.D.; Pitchumoni, C.S. 2005: Drug-induced pancreatitis: an update. Journal of Clinical Gastroenterology 39(8): 709-716
Hauben, M.; Reich, L. 2004: Drug-induced pancreatitis: lessons in data mining. British Journal of Clinical Pharmacology 58(5): 560-562
Hobolth, N. 1959: Drug-induced paralytic ileus, with potentiation by rontyl, a chlorothiazide derivative. Ugeskrift for Laeger 121(13): 504-506
Nguyen, N.; Pradel, V.; Micallef, J.ël.; Montastruc, J.-L.; Blin, O. 2004: Drug-induced parkinson syndromes. Therapie 59(1): 105-112
Van Gerpen, J.A. 2002: Drug-induced parkinsonism. Neurologist 8(6): 363-370
Mena, M.A.; de Yébenes, J.G. 2006: Drug-induced parkinsonism. Expert Opinion on Drug Safety 5(6): 759-771
Rosen, A. 1963: Drug-induced parkinsonism and its treatment with Akineton. Therapeutische Umschau. Revue Therapeutique 20: 9-12
Hermida, J.-S.; Six, I.; Jarry, G.èv. 2007: Drug-induced pericarditis mimicking Brugada syndrome. Europace: European Pacing Arrhythmias and Cardiac Electrophysiology: Journal of the Working Groups on Cardiac Pacing Arrhythmias and Cardiac Cellular Electrophysiology of the European Society of Cardiology 9(1): 66-68
Yates, R.C.; Olson, K.B. 1961: Drug-induced pericarditis. Report of three cases due to 6-amino-9-D-psicofuranosylpurine. New England Journal of Medicine 265: 274-277
Reasor, M.J.; Hastings, K.L.; Ulrich, R.G. 2006: Drug-induced phospholipidosis: issues and future directions. Expert Opinion on Drug Safety 5(4): 567-583
Huggins, J.T.; Sahn, S.A. 2004: Drug-induced pleural disease. Clinics in Chest Medicine 25(1): 141-153
Yamasawa, H.; Sugiyama, Y.; Bando, M.; Ohno, S. 2008: Drug-induced pneumonitis associated with imatinib mesylate in a patient with idiopathic pulmonary fibrosis. Respiration; International Review of Thoracic Diseases 75(3): 350-354
Boudouresques, J. 1958: Drug-induced polyneuritis. La Revue du Praticien 8(8): 839-842
Heist, E.K.; Ruskin, J.N. 2005: Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians. Heart Rhythm 2(2 Suppl): S1-S8
White, P.F.; Abrao, J. 2006: Drug-induced prolongation of the QT interval: what's the point?. Anesthesiology 104(2): 386-387
Vohra, J. 2003: Drug-induced prolonged repolarisation (acquired long QT syndrome) arrhythmias. Heart Lung and Circulation 12(Suppl 2): S85-S89
Hollister, L.E. 1962: Drug-induced psychoses and schizophrenic reactions: a critical comparison. Annals of the new York Academy of Sciences 96: 80-92
Bayerlein, K.; Frieling, H.; Beyer, B.; Kornhuber, J.; Bleich, S. 2004: Drug-induced psychosis after long-term treatment with levetiracetam. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 49(12): 868
Dore, G.; Sweeting, M. 2006: Drug-induced psychosis associated with crystalline methamphetamine. Australasian Psychiatry: Bulletin of Royal Australian and New Zealand College of Psychiatrists 14(1): 86-89
Müller, K.-M.; Einsfelder, B.M. 2006: Drug-induced pulmonary damage. Der Pathologe 27(1): 19-26
Lee-Chiong, T.; Matthay, R.A. 2004: Drug-induced pulmonary edema and acute respiratory distress syndrome. Clinics in Chest Medicine 25(1): 95-104
White, D.A. 2004: Drug-induced pulmonary infection. Clinics in Chest Medicine 25(1): 179-187
Kao, L.W.; Furbee, R.B. 2005: Drug-induced q-T prolongation. Medical Clinics of North America 89(6): 1125-1144 X
Bagshaw, S.M.; Cload, B.; Gilmour, J.; Leung, S.T.; Bowen, T.J. 2003: Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration. Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 90(5): 572-575
Frangos Lordos, E.; Trombert, V.; Kuzmanovic, I.; Vogt-Ferrier, N.; Perrenoud, J.-J. 2005: Drug-induced refractory arterial hypertension. Revue Medicale Suisse 1(39): 2522; 2525-2526
Servais, A.; Daudon, M.; Knebelman, B. 2006: Drug-induced renal calculi. Annales d'Urologie 40(2): 57-68
Joannidis, M. 2004: Drug-induced renal failure in the ICU. International Journal of Artificial Organs 27(12): 1034-1042
Beraru, V. 2006: Drug-induced retinopathies. Oftalmologia 50(3): 86-93
Mah Ming, J.B.; Gill, M.J. 2003: Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. Aids Patient Care and Stds 17(5): 207-210
Hoffer, A.; Callbeck, M.J. 1960: Drug-induced schizophrenia. Journal of Mental Science 106: 138-159
Greco, D.; Angileri, G. 2004: Drug-induced severe hypoglycaemia in Type 2 diabetic patients aged 80 years or older. Diabetes Nutrition and Metabolism 17(1): 23-26
Valhovd, M.; Kildahl-Andersen, O. 2003: Drug-induced severe jaundice. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(9): 1202-1203
Katabami, T.; Iwamoto, T. 2006: Drug-induced sexual and gonadal disorders. Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl 2: 321-325
Leong, R.W.L.; Chan, F.K.L. 2006: Drug-induced side effects affecting the gastrointestinal tract. Expert Opinion on Drug Safety 5(4): 585-592
Obtułowicz, K. 2003: Drug-induced skin allergy. Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(84): 593-597
Gallagher, C.T.; Searle, M.S. 2003: Drug-induced stabilisation of a mismatched C-T base pair in a DNA hairpin. Chemical Communications 15: 1814-1815